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Abstract
MicroRNAs (miRNAs) are small non-coding RNAs which regulate gene ex-
pression post-transcriptionally, by binding to specific mRNAs. It has been
suggested that miRNAs have a role in "canalising" development and reduc-
ing variability in gene expression.
Using conditional deletions of the miRNA biogenesis enzyme Dicer in mice,
I investigated the effect of miRNA depletion on gene expression during T-
cell development. I used flow cytometry to obtain the distribution of pro-
teins on a single cell basis. Proteins encoded by miRNA-regulated transcripts
showed a Dicer-dependent increase in both mean protein expression and cell-
cell variation. In particular, the genes Sca-1 and Cd44 show increased expres-
sion and cell-cell variation in Dicer-deleted double positive thymocytes, and
Cd69 showed increased expression and cell-cell variation in Dicer-deleted
thymocytes activated by stimulation of the T-cell receptor. Using fluores-
cent reporter constructs, the effect of the 3’ UTR of each mRNA on reporter
expression was investigated to find miRNA binding sites. I identified bind-
ing sites for the miR-181, miR-130 and miR-20 miRNA families in the Cd69 3’
untranslated region (UTR). To further investigate how these miRNAs might
regulate the expression of Cd69, I investigated how expression of miRNAs
changed on T-cell activation: observing that the miR-181 family is downreg-
ulated after activation in thymocytes, and the miR-20 family is upregulated
after activation in both thymocytes and mature peripheral T-cells. I used both
miRNA inhibitors and deletion of specific miRNA families to confirm that
the miR-181 and miR-20 families both regulate expression of Cd69 during
thymocyte activation. Finally, I looked at theoretical models of how miRNAs
might regulate biological noise, and found that the feedforward loop motif
can reduce noise compared to an unregulated gene under conditions of mod-
erate miRNA repression. These results show that depletion of miRNAs can
result in increased cell-cell variation in developmentally regulated thymo-
cyte genes.
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1Introduction
Development in multicellular organisms is a remarkably precise and robust pro-
cess, with even the simplest of multicellular organisms requiring the co-ordination
of the expression of thousands of genes across many different cell types. During
development, cells develop from pluripotent progenitor cells to become progres-
sively more specialised and spatially organised into tissues and organs. In 1957
Conrad Waddington suggested that the increasing specialisation and commit-
ment of cells during development could be visualised as a marble rolling down a
slope from the highest point, with different ridges and valleys separating differ-
ent developmental pathways, a metaphor he termed the “epigenetic landscape”.
Crucial to this view of development is the idea of “canalisation”: that mecha-
nisms exist which separate these pathways and keep them distinct, preventing
abnormal gene expression and development1. While many of the pathways in-
volved in differentiation have been, or are being, elucidated, the mechanisms be-
hind canalisation remain relatively unknown. How do organisms cope with per-
turbations to developmental pathways, and ensure that development is robust
in the face of internal and external challenges? Canalisation can occur at several
levels: for example, by the silencing of non-lineage-specific genes in a particular
cell type through the expression of a transcriptional repressor, or by changes in
chromatin structure. In particular, as the tools and techniques required to look
at cell biology in a quantitative manner have developed, it has emerged that the
stochastic nature of biochemical reactions can lead to significant deviation from
optimal patterns of gene expression. This has in turn lead to investigation into
15
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the mechanisms which control this “biological noise”.
1.1 Biological noise
Biochemical events within the cell are caused by chemical reactions between one
or more molecules. Because a chemical reaction is dependent on the reactants
meeting with the appropriate energies, each reaction is essentially a random dis-
crete event, with a probability dependent on a number of factors, principally the
concentration of reactants in the system. For many chemical processes, such as
diffusion, the number of molecules and reactions involved is large enough that
the random effect of single reactions can be considered to “average out”, and
the variation in the system is negligible. As the number of reacting molecules
gets smaller, however, the significance of stochastic effects in a system increases.
These stochastic effects present a particular issue in biological systems, as such
systems often involve relatively few reacting molecules: for instance, in transcrip-
tion and translation there are usually only one or two copies of a particular gene,
and often less than 100 mRNA molecules produced from a specific gene2. This
problem is compounded by the interconnected nature of biological networks: for
example, a relatively small deviation from normal gene expression may be ampli-
fied by downstream mechanisms3. How organisms regulate these variations in
the output of biochemical reactions, and prevent them causing potentially dam-
aging problems, is still a poorly understood area of cell biology.
Biochemical noise is commonly observed as variation in gene expression be-
tween otherwise similar cells. The first observations of such cell-cell variation
were made in bacteria, where variable responses to antibiotic treatment or bac-
teriophage infection were observed4,5. More recent experiments have used ex-
perimental techniques such as fluorescent reporter proteins, which allow the ex-
pression of particular genes to be observed at the single cell level with either flu-
orescence microscopy or flow cytometry. This has allowed the variation of gene
expression to be observed across populations and some basic principles of noise
to be determined.
Quantifying biological noise requires a reliable measure of cell-cell variation
in gene expression: several different statistical measures have been used, depend-
16
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ing on the systems investigated and the methods used. The simplest, and most
common measure of population variation is the standard deviation, alternatively
known as σ, a mathematical measure of population spread calculated as:
σ =
√
1
n− 1
n
∑
i=1
(xi − µ)2
Where n is the number of samples, µ is the population mean and x1 . . . xn are
the individual expression values. Standard deviation is a statistical measure used
in many fields other than biology. However, there is evidence that in biological
systems the standard deviation may change proportionally with the mean ex-
pression6. To investigate systems where both a change in cell-cell variation and
a change in mean levels of gene expression is seen, a measure of noise is needed
that is unaffected by change in the mean level of gene expression. To achieve
this, another commonly used measure of noise is the coefficient of variation (CV),
calculated as:
σ
µ
This normalises the standard deviation by the mean level of expression. There
are several other possible measures of variation, most significantly the noise
strength, also known as the Fano factor, calculated as:
σ2
µ
The noise strength is often used in theoretical studies of noise. This is because
Poisson processes, a class of random processes often used to simulate the occur-
rence of random chemical reactions (as well as other random processes, such as
radioactive decay), have a noise strength of 1, making the noise strength a conve-
nient measure of noise relative to a simple random process7.
A number of theoretical studies have looked at biological systems from a
mathematical viewpoint, modelling biological systems as deterministic (noise-
free) or stochastic (containing a random component) differential equations, which
17
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can be solved to obtain testable hypotheses about how biological systems might
behave. Where systems are too analytically complex to solve directly, simula-
tions of biological systems have been developed to analyse how they might be-
have. These studies often use some version of the Gillespie algorithm8, a com-
putational simulation method in which a system is represented by the levels of
each of the reagents and products: individual chemical reactions are modelled as
exponentially distributed random events, with the time to a reaction having the
cumulative distribution function
F(t) = 1− e−λt
Where F(t) is the probability of the event occurring within time t. The con-
stant λ is the key parameter determining the expected time until an event occurs;
this constant may depend on the concentration of one of more reagents: in bio-
logical reactions with one limiting component, λ is often defined as
λ = k[reagent]
Where k is the rate constant for that reaction, and [reagent] is the concentra-
tion of the reagent. More complex reactions may depend on the levels of many
reagents, or respond to changes in concentration of reagents in a non-linear man-
ner. In the Gillespie algorithm, the time to a reaction is randomly generated from
an exponential distribution given the concentration of reagents. The levels of
reagents are altered to reflect the reaction that has occurred, and another chem-
ical reaction is simulated: this is repeated until the required length of time has
been simulated. By averaging the behaviour of many iterations of a simulations,
characteristics of the system such as the mean or standard deviation of the con-
centrations of reagents can be calculated. Simulations are particularly important
for looking at biological noise, which cannot be modelled with deterministic dif-
ferential equations and which is often too mathematically complex to allow a
direct solution using stochastic differential equations.
Noise in gene expression varies between genes9, and can be broken down
into two main categories depending on where the noise originated: extrinsic and
18
1.1 Biological noise
intrinsic noise10. Extrinsic noise is due to sources that are external to the expres-
sion of that particular gene, such as variation of other pathway components (such
as upstream transcription factors), or of global factors (such as the cell cycle, or
the availability of ATP)11–13. Intrinsic noise is inherent to the process of gene ex-
pression, and can be further subdivided into components such as transcriptional
and translational noise3,14. The relative magnitude of these different categories
of noise depends on the gene and organism observed: early work on noise was in
prokaryotes such as E.coli and B.subtilis, and suggested that most intrinsic noise
in gene expression was due to “translational bursting”, where the relatively small
number of mRNAs produced in the cell at any time results in bursts of transla-
tion as one mRNA is produced, translated multiple times, and then degraded,
although changes in the rate of transcription still contribute to the noise14,15.
In eukaryotes such as S.cerevisiae, patterns of intrinsic noise are considerably
different: instead of translation being the major source of noise, transcriptional
bursting is the major source of intrinsic noise in gene expression16. In transcrip-
tional bursting, rather than transcribing genes at a fixed rate that is changed by
the binding of particular transcription factors or repressors, transcription occurs
in bursts. A given promoter can be either in a high-expression state, where it will
produce mRNAs at a high rate, or a low expression rate, where mRNA produc-
tion is negligible. The reasons for these transitions have yet to be experimentally
elucidated, but as transcriptional bursting is mainly found in eukaryotes, it has
been suggested that the bursting is due to changes in chromatin structure or bind-
ing of eukaryote-specific components of the transcriptional machinery. Experi-
mental measurement of this bursting effect in mammalian cells with fluorescent
reporters or mRNA fluorescent in situ hybridisation (FISH) show that it repre-
sents a significant proportion of intrinsic noise in mammalian cells, although this
varies between genes2,16,17.
Variation in gene expression is generally considered a negative factor in de-
velopment, potentially leading to deleterious over- or under-expression of genes.
For example, it has been suggested that accumulation of non-genetic heterogene-
ity may lead to tumourogenic phenotypes such as increased cell proliferation18.
Stochastic gene expression may also enhance cancer survival by generating a
more diverse population which is better able to respond to challenges from a
19
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changing environment: in some human cell lines, variation of gene expression
has been shown to increase the diversity of responses to challenges such as pro-
apoptotic ligands19. However in some contexts variation in gene expression may
be advantageous: several systems have been described which rely on stochastic
expression of particular genes to make decisions between different cell fates. Typ-
ically, a small stochastic difference in the expression of a particular gene between
cells is amplified by positive feedback mechanisms to determine what fate a cell
adopts. One of the most well-characterised gene regulatory networks, the deci-
sion between lysis and lysogeny in lambda phage, is determined stochastically by
the relative abundance of the fluctuating Cll and Cro proteins20. In Drosophila, the
stochastic expression of the spineless gene determines which of two fates a partic-
ular ommatidia will adopt21. Cell fate decisions in mammals may rely on similar
mechanisms: one recent study on noise in haematopoietic progenitors found that
fluctuations in expression of haematopoietic marker Sca-1 could bias populations
towards either the erythroid or myeloid lineages22, although subsequent dissec-
tion of this system suggests that stochastic expression of many additional genes
are involved23. Similarly, studies of reprogramming in induced pluripotent cells
have found that reprogramming by expression of Oct4, Sox2, Klf4, and c-Myc is a
randomly determined process24.
The mechanisms by which noise is regulated within the cell remain mostly
unknown: this is partly due to the complexity of systematically analysing or
stochastically modelling gene networks to investigate noise. One important sim-
plifying concept is that genes are found as part of “network motifs”: small sub-
networks which occur in many different parts of a genetic network (Figure 1.1).
In particular, the negative feedback loop has been suggested as a mechanisms to
reduce noise, and to prevent noise being propagated and amplified during devel-
opment (Figure 1.1a). The negative feedback loop, where one downstream com-
ponent of the motif produces a product which negatively regulates an upstream
component, is probably the most well known network motif, and has been pre-
dicted to reduce variation in both in silico simulations and artificially constructed
gene networks in vitro3,25. A second network motif, known as the feedforward
loop (FFL), has been suggested as another mechanism to reduce noise. An FFL
consists of an upstream regulator which regulates a downstream target by two
20
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different routes: a direct regulation, and by regulating an intermediate target that
in turn also regulates the downstream target. FFLs can be broadly divided into
coherent FFLs (Figure 1.1b), where both the direct interaction between the up-
stream regulator and the downstream target and the indirect interaction through
the intermediate regulator have the same effect (up- or down-regulation), and
incoherent FFLs (Figure 1.1b), where the direct and indirect interactions have
the opposite effects (ie. if the direct interaction increases expression, the indi-
rect interaction decreases expression, or vice versa). The FFL is more complex
than a negative feedback loop, but it is thought that some configurations may
reduce noise in systems by a number of mechanisms. Coherent FFLs may act
to reduce noise by adding redundancy to a system, for example by repressing
inappropriate gene expression through both direct and indirect regulation. In-
coherent FFLs may play a number of roles, depending on the dynamics of the
components: one suggestion is that FFLs reduce noise by buffering downstream
targets from noise in the upstream regulator. For example, a transient variation in
the level of a transcription factor would produce a similar variation in its down-
stream targets, leading to the propagation of noise. If the transcription factor is
part of an incoherent FFL, then this transient variation would be countered by an
opposite variation produced through the indirect pathway of the FFL, resulting
in reduced noise in the FFL targets. Computer simulations of some configura-
tions of FFLs have supported this idea, showing that noise can be reduced by
commonly found FFL configurations26, as well as possessing other useful char-
acteristics such as improved signal responses27. While these network motifs can
be found in many gene regulatory networks, it has been suggested that the class
of small non-coding RNAs known as MicroRNAs (miRNAs) may have a particu-
larly important role in reducing cell-cell variation and increasing the robustness
of genetic networks to biochemical noise28.
1.2 MicroRNAs
First identified in C.elegans, miRNAs are small (20-22 nt) non-coding RNAs that
repress specific target mRNAs29 and play a role in a large number of biological
processes, including cell differentiation, cell cycle regulation and developmental
21
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patterning, as well as in a number of diseases, such as cancer30. Approximately
500 miRNAs have been identified so far in mice, generally from sequencing of
small RNAs31. MicroRNAs are members of the family of small RNAs which also
includes short interfering RNAs (siRNAs) and Piwi-associated RNAs (piRNAs).
Similarly to miRNAs, siRNAs are also 22nt RNAs which are processed by Dicer
and act in complex with members of the Ago family. Unlike miRNAs, siRNAs are
formed from double-stranded RNA molecules (dsRNA) which can be a product
of transcription or exogenous to the cell (for example, from viral infection), and
generally bind to mRNA sites with exact complementarity and direct endonucle-
olytic cleavage of their target miRNA32. The mechanisms of piRNA biogenesis
and function are less well understood. They tend to be 20-32 nt in length, and are
processed in a Dicer-independent manner, and are generally found only in germ
line cells, where they are thought to act to repress transposable elements32.
The role of many miRNAs remains unknown, however, and the effect of in-
dividual miRNA knockouts is often phenotypically small33, although as a class
of regulators they are essential for mammalian development34. Because of this,
it has been suggested that they may play a role in maintaining the robustness
of gene expression networks to external perturbations and fluctuations in gene
expression28.
1.2.1 Biogenesis
1.2.1.1 Transcription
MicroRNA genes can be found in intergenic regions, transcribed by a separate
promoter. Alternatively, miRNAs may be encoded in the introns of protein-
coding or non-coding transcripts, where they may use their own promoter or the
promoter of the host gene35. In both intronic and non-intronic sites, miRNAs may
be found either alone or as part of a polycistronic cluster of several miRNAs36.
Identification of miRNA promoters shows that they are usually transcribed by
RNA polymerase II (or, less commonly, RNA polymerase III), and that miRNA
promoters share many features and characteristics with mRNA promoters, such
as TATA and BRE elements35. Once transcribed, most miRNA transcripts are
capped and polyadenylated in a similar manner to protein-coding mRNAs, and
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Figure 1.2: Transcription, processing and action of microRNAs - Figure showing
simplified pathways of miRNA biogenesis and action.
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contain one or more 70 nt stem-loop structures containing a mature miRNA se-
quence; this stage of processing is known as the primary miRNA (pri-miRNA)37.
1.2.1.2 Nuclear processing
Following transcription, the majority of pri-miRNAs are processed by a nuclear
complex known as the Microprocessor complex. In mice and humans, this com-
plex contains the RNAse III Drosha and the RNA-binding protein DGCR8, both of
which are required for miRNA processing38,39. Drosha contains two RNAse do-
mains, A and B, which respectively cleave the 3’ and 5’ strands of the stem-loop to
release the stem-loop from the pri-miRNA40. The resulting 70nt RNA stem-loop
is known as a precursor-miRNA (pre-miRNA). Following Drosha processing, the
pre-miRNA is exported from the nucleus by exportin-5 and Ran-GTP41.
1.2.1.3 Cytoplasmic processing
In the cytoplasm, the pre-miRNA is further processed into the mature miRNA
by the RNAse III Dicer in complex with TRBP and, in humans, PACT42,43. Dicer
cleaves the pre-miRNA hairpin, by binding to the pre-miRNA with a PAZ do-
main and cleaving the RNA with an RNAase III domain, (facilitated by a heli-
case domain)44. This produces a 21 nt dsRNA with a 2 nt 3’ unpaired overhang
and a 5’ phosphate, from which one of the strands is then degraded to leave
the mature miRNA. Which of the two pre-miRNA strands becomes the mature
miRNA is generally determined by the thermodynamic stability of the 5’ end of
each strand: the strand with the less stable 5’ end becomes the mature miRNA,
and the remaining strand is normally degraded. In some cases, both strands of
the pre-miRNA can become mature miRNAs45,46.
Following miRNA processing, TRBP recruits a member of the Argonaute (Ago)
family of proteins and the mature miRNA is incorporated into the RNA Induced
Silencing Complex (RISC)47,48. The Argonaute family of proteins is the key ef-
fector of miRNA-mediated mRNA repression. Argonaute family members, of
which there are four members in humans and five members in mice, are com-
posed of three main domains: the PAZ, PIWI and MID domains, which each play
a role in miRNA binding and action49. Structural studies show that the PAZ do-
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main binds the 3’ overhang of miRNAs while the PIWI and MID domains bind
the 5’ end of the miRNA50. In some members of the Ago family, particularly
Ago2 in humans, the PIWI domain is catalytically active, and capable of acting
as an RNAse by cleaving targets bound to it, but this is not generally the case
in miRNA-mediated repression51. The role of the different members of the Ago
family in the RISC remains unclear, but it is thought that in humans, they all
contribute to miRNA-mediated repression51,52, although there is some evidence
that different members of the Ago family may be associated with different mecha-
nisms of mRNA degradation53, or have differing levels of repressive efficacy54,55.
As well as Dicer, TRBP, and the Ago family, other, less-well characterised proteins
have also been identified as part of the RISC, including a number of helicases and
RNA-binding proteins56–58. The mature miRNA-incorporating RISC (miRISC)
can then target mRNAs for repression.
1.2.2 MicroRNA targeting
The miRISC targets specific mRNAs which contain a binding site for that miRNA
family, principally determined by complementarity to the seed sequence of the
miRNA. The seed sequence is a 7 nt sequence found at positions 2-8 of the 5’ end
of the miRNA, which is common to all members of a particular miRNA family59.
While complementarity to a miRNA seed sequence is an important determinant
of miRNA binding affinity, it is not sufficient or necessary for miRNA action,
and several other features can enhance miRNA binding. Computational predic-
tion of miRNA binding sites using seed sequence complementarity often has to
use additional features, such as conservation or increased AU content in the rest
of the miRNA binding site, to detect potential sites with accuracy60,61. Another
commonly found feature of miRNA binding, which distinguishes miRNAs from
siRNAs, is the lack of complementarity around bases 10-11 of the short RNA.
MicroRNA binding sites are most commonly found in the 3’ untranslated re-
gion (UTR) of mRNAs, but have also been found in the 5’ UTR or in coding re-
gions62,63. Computational prediction of miRNA binding sites in humans suggests
that many thousands of mRNAs, or up to 60% of all genes, may contain miRNA
binding sites64,65. However, despite this growing understanding of the determi-
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nants of miRNA binding, computational target prediction still has a high level
of negative predictions: proteomic studies of miR-233-depleted cells showed that
while Targetscan is the most effective algorithm for prediction of miR-233 bind-
ing sites, only 33% of predicted sites were more responsive than transcripts with
no predicted sites66,67. Interestingly, recent analysis of data from miRNAs and
mRNAs bound to Ago and pulled down by crosslinked immuno-precipitation
has identified an additional binding mode for miRNA targets characterised by a
bulged G nucleotide at position 5-6 of the miRNA binding site. This mechanism
may account for around 15% of miRNA binding, suggesting that exact seed se-
quence complementarity may be a less important determinant of miRNA binding
than previously thought68.
1.2.3 Mechanisms of miRNA action
The repressive effect of miRNA targeting is well documented, but the mechanism
by which it occurs remains controversial. In plant miRNA and in mammalian
siRNA pathways, the RISC complex works by cleaving the targeted transcripts
between bases 10 and 11 of the siRNA binding site, resulting in the endonucle-
olytic cleavage and degradation of the transcript, but this mechanism is rare in
mammalian miRNAs69. Several possible modes of action have been suggested,
including sequestration of targeted transcripts away from the translational ma-
chinery in P-bodies or stress granules, mRNA degradation triggered by removal
of mRNA associated proteins or the mRNA poly-A tail, and inhibition of transla-
tional initiation or of translational elongation70–72. Experimental evidence exists
for each of these mechanisms: it seems likely that in reality the miRISC works at
multiple stages of gene expression.
1.2.3.1 Translational inhibition
Early miRNA experiments suggested that repression by miRNAs was entirely
due to inhibition of translation, and that target mRNA levels were unchanged73.
While repression of translation is no longer thought to be the exclusive mecha-
nism of miRNA-mediated repression, translational repression remains a contro-
versial area of research, particularly the stage of translation at which inhibition
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occurs: conflicting evidence exists that inhibition occurs during both the initia-
tion and elongation steps.
The idea that miRNAs repress translation in a post-initiation step was first
suggested when it was observed that, in C.elegans, miRNAs and miRNA tar-
gets localised with polysomes in sucrose gradient fractionation, suggesting that
targeted mRNAs remained associated with ribosomes while repressed73. How-
ever, subsequent studies have found conflicting results, with some showing that
miRNAs and their targets localise with polysomes (and dissociate when treated
with inhibitors of translation, such as puromycin)74–76, while others show that
miRNA repression results in a shift in targeted mRNAs from the polysome frac-
tion into lighter fractions, consistent with inhibition of translational initiation77–79.
The reasons for this apparent contradiction remain unclear, but one possibility is
that moderate miRNA repression does not prevent all translation despite target-
ing by the RISC, resulting in the complex being associated with polysomes72.
Supporting the idea that translational repression occurs at the initiation stage
of translation, several studies have found that the m7-G-cap and poly-A tail found
on mRNAs are required for miRNA repression of reporter genes, suggesting that
miRNA action interferes with the proteins that bind to these structures and ini-
tiate translation, such as the cap-binding translation initiating factor eIF4F. Cap-
independent translation, such as from an IRES or using tethered initiation factors,
was unaffected by miRNA repression, which supports this idea78,80–82. How-
ever, other studies have shown that miRNA inhibition of translation from IRES-
containing transcripts can occur62,76, and there is no clear way to reconcile these
contradictory observations. One potential, but still controversial, solution is that
miRNA regulation may depend on the promoter driving transcription of the tar-
get: this was proposed in a study which showed that transcripts from the TK
promoter localised with polysomes, while the same transcript produced from the
SV40 promoter did not83. If miRNA repression of translation can occur post-
initiation, a clear mechanism has yet to emerge. One suggested mechanism was
the recruitment of proteases that co-translationally degrade the nascent polypep-
tide75. However, targeting polypeptides to the ER, which should render them
inaccessible to cytoplasmic proteases, has no effect on miRNA repression78. An
alternative theory is that miRNA targeting produces a reduction in translation
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rates resulting in an increased probability of ribosome drop-off76, but no clear
evidence has emerged supporting either mechanism. There is still considerable
controversy over the mechanisms of translational repression: strong evidence ex-
ists that repression occurs at the initiation stage, through the disruption of the
assembly of the ribosomal initiation complex, but this does not explain a signifi-
cant number of contradictory studies which suggest that translation is inhibited
after inhibition by an unknown mechanism.
1.2.3.2 mRNA degradation
While translational inhibition was originally thought the be the only source of
miRNA repression, considerable evidence has emerged, from both microarray
profiling and studies of individual miRNAs, that miRNAs also cause degrada-
tion of target mRNAs54,84,85. Studies in a number of systems suggest that this
degradation is mediated by removal of the poly-A tail and subsequent diges-
tion by RNA exonucleases86,87. In particular, miRNA-mediated degradation has
been linked to proteins commonly found in structures known as P-bodies (or
GW-bodies), which have been associated with many proteins involved in mRNA
degradation, such as the endonuclease XRN1, as well as decapping and dead-
enylating enzymes88. The protein GW182, which is localised to P-bodies, has
been found to interact with and localise with Ago proteins. Silencing of GW182
reduces repression of miRNA targeted proteins, and disrupts P-bodies89–91, and
tethering of GW182 to mRNAs results in their repression, even in the absence of
Ago proteins, suggesting that GW182 operates downstream of Ago proteins92.
Argonaute proteins, miRNAs and repressed mRNAs have all been found to lo-
calise to P-bodies78. GW182 may promote degradation by recruiting the dead-
enylation complex CCR4:NOT1 and the decapping complexes DCP1:DCP2 or
RCK/p5492,93.
While miRNA-directed transcript degradation is now an accepted compo-
nent of miRNA-mediated repression, which factors determine the degree of ei-
ther mRNA degradation or translational inhibition are still poorly understood:
proteomic studies have shown that most miRNA targets are repressed at both the
protein and mRNA level66,67. Recent studies have also shown that translational
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inhibition occurs before mRNA-degradation: For example, studies of the impact
miR-430 on transcript localisation in zebrafish show that the level of ribosome-
associated transcripts drops before the level of transcripts, indicating that trans-
lational inhibition occurs before mRNA degradation94.
1.2.3.3 mRNA sequestration
While the Ago-GW182 interaction was thought to be primarily associated with
miRNA degradation, interactions with GW182 also localise RISCs and targeted
mRNAs to P-bodies78, suggesting that there may also be a repressive effect from
physically isolating transcripts from the ribosomal machinery. Other studies have
shown that miRNA repression may be reversible under certain conditions95,96.
Investigation of the miRNA target CAT-1 showed that induction of the stress re-
sponse resulted in the release of CAT-1 mRNA from P-bodies, suggesting that not
all miRNAs in the P-bodies are degraded79. This suggests another mechanism
of miRNA repression: mRNA transcripts could be reversibly sequestered in P-
bodies, away from the ribosomal machinery, to prevent protein synthesis. How-
ever, profiling studies of P-body mRNA populations in glucose-starved yeast
have shown that only a small number of transcripts are reversibly sequestered,
with the majority being degraded in P-bodies, suggesting that the majority of
miRNA-targeted transcripts sequestered to P-bodies are degraded97. Further-
more, other studies have shown that P-bodies, unlike Ago and GW182, are not
required for miRNA-mediated repression: disruption of P-bodies by depletion of
P-body components such as Lsm1 do not affect repression93.
Stress granules are cytoplasmic structures formed in cells under stress con-
ditions or conditions of translational inhibition98. As well as enrichment in P-
bodies, studies have also shown enrichment of Ago proteins in stress-granules
in a miRNA-dependent manner99. However, it is not clear if this is a pathway
for repression or an artefact of mRNAs, and their associated proteins (such as the
miRISC), localising to stress granules under stress conditions.
It is not yet clear which of these mechanisms of repression is most common:
high-throughput proteomic studies have shown that miRNA targeting results in
repression of both the protein and mRNA, suggesting that in most cases more
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than one of these mechanisms actually occurs66,67. Furthermore, it is possible
that these translational inhibition and mRNA degradation are actually coupled,
so that translational repression may feed into mechanisms of mRNA degradation,
for example by recruiting proteins that result in mRNA degradation100.
1.2.3.4 Non-canonical miRNA pathways
As well as the classic “canonical” pathways for miRNA biogenesis and action,
a large number of less common mechanisms of biogenesis, processing and ac-
tion have been observed for specific miRNAs. For example, while the major-
ity of miRNAs are processed into pre-miRNAs by Drosha, there are Drosha-
independent modes of processing, such as the miRtron pathway, where a miRNA-
containing intron is processed into a pre-miRNA by the splicing machinery in a
Drosha-independent manner101.
As well as repressing translation of proteins and degrading mRNAs, there
is some suggestion that miRNAs may have a role in post-transcriptional gene si-
lencing: this is a well-documented function of miRNAs in plants, but evidence for
it in animals remains controversial: one recent study in fibroblasts showed that
AGO proteins can localise to the nucleus and associate with heterochromatin, and
that transcription from reporters containing miRNA-binding sites was reduced in
the presence of miRNAs102, but evidence for miRNA-mediated silencing remain
rare.
Finally, there is some evidence that miRNAs may also have a role in the up-
regulation of specific transcripts, possibly by the recruitment of upregulating pro-
teins or by competing with other repressive factors. These effects seem to occur
at specific stages of the cell cycle and in conditions of cell-cycle arrest, which may
explain why these effects had been previously overlooked103–106.
1.2.3.5 Modulators of miRNA action
Many miRNAs are also regulated post-transcriptionally by specific proteins: for
example, the protein Lin28 has been found to block the processing of members
of the let-7 family of miRNAs in embryonic cells, resulting in reduced levels of
mature miRNAs107. A number of mechanisms for this action have been proposed
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including inhibition of processing of let-7 members by Drosha in the nucleus and
inhibition of Dicer processing in the cytoplasm, either directly or by uridylation
of the 3’ end of the pre-miRNA in the cytoplasm108–110. Conversely, the SMAD
family of proteins can promote processing of miR-21 in response to TGF-β or BMP
signalling by binding to p68, a helicase which can form part of the microproces-
sor complex111. Individual studies and high throughput sequencing have also
found that many miRNAs are post-transcriptionally edited, replacing adenosine
residues with inosine residues: the effect of this modification is poorly under-
stood, but may trigger inhibition of Dicer activity or degradation of modified
miRNAs31,112. Some proteins may directly repress miRNA action: the mRNA-
binding protein HuR has been found to relieve repression of the CAT-1 mRNA by
miR-122, potentially by changing mRNA folding to render the miR-122 binding
site inaccessible79. This wide range of miRNA-modulating proteins adds another
layer of regulatory complexity to miRNA-mRNA interactions.
One particularly interesting area of research has been the role of miRNAs as a
medium for intracellular signalling. Recent research has shown the miRNAs can
allow cross-talk between particular RNA transcripts, so that if one transcript con-
taining a number of miRNA binding sites is expressed, this depletes the available
“pool” of those miRNAs available to bind other transcripts, reducing the repres-
sive effect of those miRNAs113.
Finally, miRNAs may not in fact function in the cell in which they are tran-
scribed: a number of studies have detected the presence of functional miRNAs
in vesicles, and shown that miRNAs may be transported to other cell types to
repress mRNAs, although this function remains controversial. For example, flu-
orescently tagged miRNAs have been found to transfer from B-cells to T-cells
on cell contact114, and miR-containing exosomes have been identified from mast
cells115.
1.2.4 MicroRNA function
While the mechanisms by which miRNA are produced and act are now well-
characterised, the role of many miRNAs remains unclear. Depletion of all mature
miRNAs by constitutive deletion of Dicer is lethal in mice, resulting in deple-
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tion of ES cells, which suggests that miRNAs play important roles in develop-
ment34 Deletion of the C.elegans Dicer ortholog dcr-1 renders C.elegans sterile116;
preventing maternal inheritance of dcr-1 by additional knockdown of maternal
dcr-1 transcripts results in lethality117. Deletion of other essential components of
the miRNA biogenesis pathway have similar effects: deletion of Drosophila TRBP
homolog loquacious results in depletion of germ-line cells and sterility118. Simi-
larly, deletion of DCGR8 in mice results in early embryonic lethality119, although
DCGR8 and Dicer mutant phenotypes show some differences, potentially because
they process slightly different subsets of miRNAs. To investigate the role of Dicer
in mouse tissues, conditional Dicer knockouts have been developed, which show
a variety of developmental abnormalities: for example, in limb development,
Dicer deletion under the control of the limb mesoderm specific promoter prx1
results in delayed development and a smaller limb bud, but no defects in pat-
terning or tissue specification120; in lung development, Dicer deletion under the
control of the shh promoter results in fewer epithelial pouches and increased cell
death121.
Investigation of the function of individual miRNAs generally show less dra-
matic effects. While miRNAs are predicted to target a large proportion of the
genome, the function of many of these interactions remains to be determined. The
first microRNAs discovered, such as the let-7 family, were identified by forward
genetic screens, linking mutated miRNAs with specific phenotypes and giving
clear evidence of the primary roles of a specific miRNA. Relatively few miRNAs
have been identified in this fashion, however, with most being identified by se-
quencing experiments122. Proteomic and microarray studies have shown that
knock-out of specific miRNAs results in relatively small changes in the expres-
sion of both mRNA and protein of a large number of genes66,67, but phenotypic
effects from specific miRNA knock-out are observed comparatively infrequently:
in C.elegans, individual mutations of 95% of known miRNAs resulted in no sig-
nificant phenotypic changes33.
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1.2.4.1 MicroRNAs in development
MicroRNAs were originally discovered as regulators of development in C. elegans
and many more instances of miRNA regulation in development of C. elegans and
other model organisms have since been discovered. In mammals, miRNAs play
a number of important roles right from the start of development: Dicer-deleted
ES cells are viable, but show proliferation defects and fail to sucessfully differ-
entiate123. These problems are thought to be due to depletion of the miR-290
family, which has been shown to regulate regulators of the cell cycle, causing
proliferation defects, and de novo methyl transferases, disrupting mechanisms of
differentiation124,125. Many MiRNAs are also found later in development: for
example, miR-196 has been found to regulate expression of Hox genes during
mouse hindlimb development126 and many other instances of miRNA regulation
in mammals and other organisms have been observed122,127,128. However, only
a small fraction of predicted miRNA-mRNA interactions during development
have been investigated: the majority have not been experimentally validated and
the significance and effects of these predicted interactions, if any, are unknown.
Some conclusions about the roles of miRNAs can be drawn from looking at the
expression patterns of miRNAs and their targets: for example, a number of tissue-
specific miRNAs have been identified, including miR-1 in muscles and miR-124
in neural tissue129.
Given these features of miRNA expression, a number of (not necessarily
contradictory) different hypotheses have been suggested for the general role of
miRNAs as a class, to explain the lack of strong interactions that have been ob-
served.
Firstly, it has been suggested that miRNAs “tune” gene expression, adjust-
ing gene expression by relatively small amounts to an optimum value, integrat-
ing the signal from many miRNAs through multiple miRNA binding sites on a
given mRNA . Some papers have described this function of miRNAs a “rheo-
stat” function, which is an analogy with the rheostat in electrical circuits, which
allows the resistance of the circuit to be varied: similarly, miRNAs allow the de-
gree of repression in a genetic network to be varied. Several papers have cate-
gorised miRNA-mRNA into “tuning” and “switch” interactions, depending on
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whether the response of the target to miRNA regulation is a small adjustment or
a large response (typically downregulation of the target to functionally negligible
levels)130. An example of a tuning interaction would be the regulation of sense-
less by miR-9a in Drosophila. The decision to adopt the sensory organ precursor
(SOP) lineage in Drosophila is made by a combination of positive feedback be-
tween proneural genes and lateral inhibition through the Notch-Delta pathways.
In particular, the transcription factor Senseless has a key role in this system: it is
upregulated by proneural transcription factors, and in turn increases the expres-
sion of proneural genes, forming a positive feedback loop, as well as increasing
the expression of Delta, which works to inhibit proneural expression in neigh-
bouring cells by activation of the Notch receptor. While the initial inputs to the
system are stochastic, the combination of positive feedback and lateral inhibition
means that only a fixed proportion of cells can become SOP precursors. In this
system, miR-9a represses Senseless expression and sets a threshold of Senseless
expression required for full activation of the positive feedback loops, essentially
tuning Senseless expression to produce the required number of sensory organs.
miR-9a-deleted flies show increased numbers of sensory neurons131.
However, this categorisation is a considerable over-simplification: much re-
pression by miRNAs cannot be clearly categorised into tuning or switch relation-
ships, and falls somewhere in between the two categories: causing significant
changes in gene expression, but not completely repressing genes66,67. This cat-
egorisation also fails to take into account the dynamic natures of gene regula-
tion: during development, gene expression is rarely static and it is not clear how
miRNAs tune a dynamically regulated gene.
Secondly, miRNAs may act to repress inappropriate gene expression: many
miRNA targets are found downregulated in tissues where the targeting miRNA
is expressed, leading to suggestions that the major role of miRNAs is to downreg-
ulate lineage-inappropriate gene expression by repressing expression of inappro-
priately transcribed mRNAs, or to sharpen developmental transitions by repress-
ing mRNAs remaining following transcriptional downregulation during a devel-
opmental change132,133. This idea was initially supported by the identification of
predicted miRNA targets that were downregulated as their targeting miRNA was
expressed133,134, and that miRNA targets were often expressed in adjacent tissues
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to those expressing targeting miRNAs132. However, it is not clear from available
data whether the downregulation seen in miRNA targets when expressed in the
same tissue is a consequence of miRNA regulation or due to transcriptional reg-
ulation, and other studies have found that many miRNA regulatory interactions
are upregulated at the same time as their targets135.
Finally, a third theory synthesises these ideas and incorporates concepts from
systems biology: miRNAs may act to increase the robustness of gene networks,
both to external challenges such as temperature change and to internal challenges
such as biological noise. This hypothesis combines the idea that miRNAs work to
downregulate inappropriately expressed genes, as well as the idea that miRNAs
can tune gene expression to appropriate levels, but also incorporates a new idea:
that miRNAs can also function as part of larger network motifs to reduce biolog-
ical noise.
1.2.4.2 MicroRNAs and noise
With a few notable exceptions, experimental deletion or depletion of specific
miRNAs often have relatively limited phenotypic effects. One hypothesis to
explain this, and to explain the general role of miRNAs has been that they act
to buffer transcriptional networks against perturbations, including biological
noise28,136. Because mature miRNAs are produced by less complex mechanisms
than proteins, it is thought that they may respond faster to transcriptional upreg-
ulation, and therefore make superior regulators in network motifs such as nega-
tive feedback loops. The short length of miRNA sequences and miRNA binding
sites also mean that miRNA-mRNA interactions need fewer mutations to form
than protein-DNA interactions, and are therefore more likely to appear during
evolution.
In particular, it has been suggested that miRNAs function as part of FFL net-
work motifs (Figure 1.1). In a miRNA-containing FFL, an upstream transcrip-
tional factor will regulate the transcription of both a miRNA and a gene which
is regulated by that miRNA. Like other FFLs, MicroRNA-containing FFLs can be
divided into two categories: coherent FFLs, where the miRNA and other com-
ponents produce the same effect on gene expression, or incoherent FFLs, where
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the miRNA and other components oppose each other. It was initially suggested
from predictions in Drosophila that the majority of FFLs were coherent loops in-
volved in reinforcing developmental boundaries132. However, more recent stud-
ies have shown that miRNA containing FFLs of both types are overrepresented in
the human genome, compared to other transcriptional motifs135,137. Both forms
of FFL have been hypothesised to increase robustness in gene expression, but
through different mechanisms. It is easy to see that coherent FFLs containing
miRNAs could reduce noise in gene expression by increasing repression of inap-
propriately expressed genes, effectively reinforcing changes in gene expression.
Because miRNAs target mRNAs, they can target remaining transcripts after tran-
scription has ceased, sharpening developmental transitions. The role of incoher-
ent FFLs is less clear, as the effect of incoherent regulation depends on the dy-
namics of miRNA-mRNA regulation, but several models of miRNA action have
suggested that they may also act to increase the robustness of gene expression.
The simplest model, suggested by Hornstein and Shomrom, is that regulation
by miRNAs allows an increased rate of transcription to compensate for transla-
tional repression. As "bursting" in transcription is the principal source of noise in
gene expression, and increasing transcription reduces the noise from "bursting",
miRNA regulation allows transcriptional noise to be reduced while maintaining
the same rate of gene expression28. An alternative suggestion is that miRNAs
act to buffer the expression of genes against extrinsic noise from upstream factors
such as transcription factors: for example, in a simple incoherent FFL, transient
increases in the expression of the upstream transcription factor will result in an
increase of transcription of both a targeted gene, and also a miRNA; the expres-
sion of the miRNA will repress translation of the downstream target, cancelling
out the effect of the transient increase in the original transcription factor. Sev-
eral, more mathematical models have also been suggested, using either direct
analytical solution of simplified models of the basic interactions in miRNA reg-
ulation (transcription, translation etc) or computational simulations which simu-
late many iterations of the system and calculate the average expression and other
statistics such as standard deviation. A number of these computational studies
have looked at miRNA-based FFLs, and have shown that miRNA-based FFLs can
reduce variation in gene expression, both compared to unregulated genes, genes
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regulated by miRNAs that are not part of an FFL, and genes regulated by pro-
tein FFLs and that miRNA-based regulation is more effective at reducing noise
than transcription factor based regulation, primarily because protein translation
requires more processing steps (ie. translation) which result in additional noise
in the system138. Other simulations have also found that regulation of gene ex-
pression at the mRNA level is more effective at reducing noise, and that miRNA-
based is more effective at filtering upstream noise than protein-based gene regu-
lation139,140.
However, most of the investigations into the role of miRNA in controlling
gene expression noise have remained in silico, and remain sensitive to the choice
of model architecture and of reaction parameters: experimental evidence for the
role of miRNAs in regulating variation in gene expression remains limited: many
coherent and incoherent FFLs have been identified, but relatively few have then
been linked directly to robustness or reduced variation in gene expression.
In Drosophila, it has been shown that knockout of miR-7, which forms part of
a complex network and regulates the enhancer of split transcription factor, cou-
pled with fluctuating temperature results in defects in sensory organ develop-
ment that are not present under stable temperature conditions, suggesting that
miR-7 increases developmental robustness to temperature variation141.
1.2.4.3 MicroRNAs in disease
MicroRNAs have been implicated in a number of diseases. Supporting the idea
that miRNAs are involved in increasing the robustness of gene expression, only
two Mendelian genetic conditions associated with mutations in miRNAs are
known, but miRNAs have been found in many diseases associated with stress
and gene disregulation, particularly cancer142.
The two known miRNA-associated mendelian genetic conditions are nonsyn-
dromic autosomal dominant progressive hearing loss, caused by mutations in the
seed sequence of miR-96143, and Feingold syndrome, which is caused mainly by
mutations in the MYCN gene, but in a minority of cases is caused by mutations in
the miR-17-92 cluster144. A large number of different miRNAs have been associ-
ated with cancer in different cell types. For example, overexpression of miR-155
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and miR-21 have both been found to result in tumourogenesis in pre-B cells145,146.
Similarly, overexpression of the miR-17-92 cluster results in accelerated tumour
development in a mouse pre-B cell model147. Conversely, other miRNAs have tu-
mour suppressive effects, such as overexpression of miR-34a or miR-143/145 in
pancreatic cancer or miR-26a in murine liver cancer148,149. MicroRNAs are often
found to be downregulated in many cancers, although whether these are required
for cancer development or merely symptoms of the gene deregulation often seen
in cancer is not known150. MicroRNAs are also often found to be deregulated in
cardiovascular disease, potentially due to their role in regulating stress pathways:
for example, inhibition of miR-15/16 increases cardiomyocyte recovery after hy-
poxia142,151.
1.3 T-lymphocytes
T-Lymphocytes, so called because they develop in the thymus, are one of the
principal components of the adaptive immune system. Because of their experi-
mental accessibility and importance to human disease, T-lymphocytes are one of
the best understood mammalian developmental systems, with many of the de-
velopmental stages, signalling pathways and transcriptional programmes well
characterised. This makes T-cell development an ideal experimental system for
studies of developmental principles. Mature T-cell populations consist of two
main cell types, T helper (TH) and T cytotoxic (TC) cells, experimentally distin-
guished by the expression of either CD4 or CD8 cell surface proteins. A smaller
population of cells expressing the γδ-TCR variant also exists, forming a separate
lineage. Each of these populations has a distinct role in the immune system. T-
helper cells secrete cytokines which can trigger responses in neighbouring cells,
while cytotoxic T-cells bind to foreign cells and trigger a number of responses
which act to kill targeted cells. T-helper cells can be further subdivided into a
number of subsets, including Th-1, Th-2, T-regulatory, and Th-17 lineages, char-
acterised by the secretion of different subsets of cytokines. Th1 cells secrete inter-
feron γ (IFN-γ) and tumour necrosis factor β (TNF-β), Th2 cells secrete a number
of interleukins (IL-4,-5,-10 and -13) while Th-17 are characterised by production
of Il-17152. T-regulatory cells have a role in suppressing the immune response,
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through mechanisms such as the secretion of immunosuppressive cytokines IL-
10 and TGF-β, and expression of immunosuppressive surface molecules such as
CTLA-4153. While many different T-cell subtypes have been identified and char-
acterised, the T-cell system also shows considerable plasticity, with a number of
cases of T-cells switching subtype or showing altered cytokine secretion in re-
sponse to particular stimuli; for example, Th-2 cells have been shown to switch
to Th-1 cells under certain conditions154,155.
1.3.1 T-cell activation
Both TH and TC cells bind to antigens displayed as part of the major histocom-
patibility complex (MHC) through the T-cell Receptor (TCR). TH cells bind to
class II MHCs, expressed by antigen presenting cells (APCs) such as B-cells, den-
dritic cells, and macrophages, while TC cells bind to class I MHC, which are ex-
pressed on the majority of cells. Binding of the MHC to the TCR in complex with
CD3 (along with costimulation of the CD28 receptor) triggers signalling path-
ways that cause a program of gene expression, cytokine secretion and differenti-
ation that is known as T-cell activation.
The TCR is a heterodimer composed of either α and β chains or γ and δ chains.
The two variants have different binding characteristics and functions: αβ TCR ex-
pressing cells are better understood, and bind to MHC-antigen to trigger canon-
ical TH or TC responses. γδ-expressing T-cells are a separate lineage (with no
TH/TC subsets) whose function is less well understood: some γδ T-cells can bind
to native antigen without requiring MHC presentation and the γδ TCR shows
limited variability compared to the αβ TCR156.
T-cell activation requires stimulation through successful binding of the TCR to
a suitable MHC-antigen complex, as well as costimulation of CD28 by members
of the B7 family. Engagement of the TCR allows phosphorylation of immunore-
ceptor tyrosine-based activation motifs (ITAMs) on the cytoplasmic domains of
TCR-associated CD3 complex by members of the Src tyrosine kinase family such
as Lck or Fyn. The mechanisms by which this is triggered are likely to be a combi-
nation of conformational change in CD3 polypeptides allowing access to ITAMS
that were previously blocked by the plasma membrane157, and aggregation of
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multiple TCR receptors (and coreceptors) to allow transphosphorylation of CD3
chains, and exclusion of inhibitory phosphatases158,159. Lck kinase binds to the
co-receptors CD4 and CD8 and, as well as phosphorylating CD3 ITAMs, also acts
to recruit CD4/8 coreceptors by binding to phosphorylated tyrosine residues via
SH2 domains160,161. The interaction of TCR and other proteins with the MHC
proteins and costimulatory ligands is sometimes referred to as the formation of
the “immunological synapse”, by analogy to neural synapses. The immunolog-
ical synapse is a complex structure, involving a large number of receptors, scaf-
folding and signalling proteins. Key among them are the members of the Syc
family, ZAP70 and Syk, which bind via SH2 domains on CD3 phosphorylation
and are in turn phosphorylated, recruiting two more key adaptor proteins, LAT
and SLP-76162–164. These proteins activate a number of different intracellular sig-
nalling pathways, as well as triggering cytoskeletal rearrangements and changes
in external cell signalling through proteins such as integrins. Three main intra-
cellular signalling pathways are triggered by T-cell activation, as briefly sum-
marised below. LAT engages PLCγ, which hydrolyses phosphatidylinositol (4,5)
biphosphate (PIP2) into diacyl-glycerol (DAG) and inositol 1,4,5 trisphosphate
(IP3). IP3 triggers calcium influx from the endoplasmic reticulum, triggering
signalling through calcium-dependent pathways such as the NFAT transcription
factor. DAG activates the Ras-ERK signalling pathway, triggering a chain of ki-
nases which results in the activation of the transcription factor AP-1. DAG also
activates PKCΘ, which allows the assembly of a membrane-bound complex of
proteins including CARMA1, BCL-10 and MALT1, known as the CBM complex
which can activate the NF-κB signalling pathway by activation of IKK, which
phosphorylates IκB, releasing NF-κB (Figure 1.3). As well as direct binding of the
TCR, binding to other co-receptors is also required for full T-cell activation: with-
out CD28 binding, TCR engagement produces a response known as “anergy”
where the cells become unresponsive to further TCR stimulus. CD28 binds to
members of the B7 family of ligands, which are highly expressed on activated
APCs, and contributes to the activation of the PI3K signalling pathway, as well as
upregulation of other T-cell activation pathways165,166. TCR and coreceptor path-
ways show considerable crosstalk and interaction, allowing modulation of the
immune response depending on what combinations of signals the TCR and other
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coreceptors have received: for example, expression of only the Ca+-induced tran-
scription factor NFAT acts to induce genes associated with anergy, but activation
of both NFAT and the AP-1 transcription factor allows expression of genes asso-
ciated with full activation167,168. T-cell activation must be highly specific to al-
low detection of a relatively small number of antigen-presenting cells displaying
pathogen-specific protein/MHC against a background of many cells displaying
self-peptide/MHC. To achieve this the signalling pathways of T-cell activation
involve a network of interactions to assure correct activation. Key among them
is “kinetic proofreading”, where for a ligand to achieve full T-cell activation, it
must bind to the receptor for long enough to recruit a number of cofactors and to
overcome a number of repressive mechanisms, such as the phosphatase SHP-1,
which dephosphorylates a number of signalling components, such as Lck169.
Full T-cell receptor signalling results in immediate activation of a number of
transcription factors, including NFAT NF-κB, c-Myc and c-Fos and c-Jun (which
are together also known as AP-1). These in turn produce a number of responses,
including upregulation of cell surface markers CD69 and CD25, expression of IL-
2 and rapid cell proliferation, as well as differentiation into effector or memory
subtypes. T-cell activation responses are rapidly induced: activation of transcrip-
tion factors takes place within 30 minutes of TCR binding, and expression of early
activation markers such as CD25 is detected within 2 hours152.
CD69 is a homodimeric cell surface glycoprotein, which is an important marker
of T-cell activation, and is strongly upregulated in T-cells immediately after ac-
tivation170. This response is thought to be driven mainly by the ERK pathway,
as expression of a dominant-negative Ras allele reduced CD69 expression fol-
lowing activation171. CD69 is also expressed on a wide variety of other cells in
the haematopoietic system, including platelets, natural killer (NK) cells and neu-
trophils172. Little is known about the biological function of CD69: studies have
shown that it has roles in TGF-β signalling, T-cell emigration and regulation of
the sphingosine-1-phosphate-receptor 1, but no ligand for it has yet been identi-
fied173–176.
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Figure 1.3: T-cell activation signalling - Simplified diagram of major components
and pathways of T-cell activation
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1.3.2 T-cell development
All types of T-cell originate from the thymus, which was first identified as a key
component of the immune system in 1961, when it was found that removal of
the thymus immediately after birth resulted in increased mortality from infection
and a reduction in the number of lymphocytes177. The development of αβ T-cells
from haematopoietic precursor cells into mature, functional components of the
adaptive immune system is a complex, multi-stage process which includes the
process of TCR rearrangement and selection. TCR rearrangement is the process
by which the loci containing the two chains of the TCR, (α and β) are rearranged
by the RAG1/2 recombinase. The resulting diversity of different receptors under-
goes selection to eliminate receptors which cannot bind MHC-antigen complexes
or which have too high an affinity for MHC presenting self antigen.
All TCR polypeptides are made up of variable and constant domains in a sim-
ilar manner to immunoglobins. During T-cell development, they undergo rear-
rangement of variable (V), diversity (D) and joining (J) gene segments to pro-
duce a complete chain containing one of each segment in a similar manner to
immunoglobins. The mouse α TCR chain has around 150 V, and 50 J segments,
while the β chain has around 20 V, 2 D and 10 J segments: successful rearrange-
ment joins one of each of the segments (V and J in α, V, D and J in β) to express a
complete variable domain178. T-cell rearrangement is catalysed by the RAG-1/2
enzyme, which binds to 7- and 9- nt recognition sequences which flank the V, D
and J segments. The RAG recombinase then excises a segment and the double-
strand-breaks that remain are repaired by components of the DNA repair path-
ways. Additional diversity is generated by the imperfect cleavage and joining of
segments, which may introduce additional nucleotides at segment junctions179.
This rearrangement process allows the generation of considerable combinatorial
diversity in TCR sequence across the thymocyte population, which is crucial for
the processes of adaptive immunity. The structure of the TCR genes is such that
a successful rearrangement of the α chain deletes the constant domain of the δ
chain, preventing co-expression of both receptors.
T-cell development begins when lymphoid precursors migrate from the bone
marrow to the thymus. As the immature T-cells mature, rearrange and express
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Figure 1.4: T-cell development - Stages of T-cell development from lymphoid pre-
cursors to mature naive T-cells, showing main identifying cell markers.
the TCR, and undergo selection, they go through a series of developmental stages
characterised by the expression of several cell surface protein markers, princi-
pally CD4 and CD8, but substages of development are characterised by other
markers. Initially, new entrants to the thymus do not express CD4 and CD8 and
are known as double negative (DN) cells. These cells are further divided into
four subsets of cells, distinguished by expression of CD25, CD44 and c-kit. Ini-
tially cells are known as DN1, and express CD44 and c-kit: after entry to the
thymus, DN1 cells proliferate and develop into DN2 cells, which also express
CD25. At the DN2 stage, cells start to undergo rearrangement of the TCR β, δ
and γ chains. As thymocytes transition to the DN3 stage, a small percentage of
cells diverges to become γδ T-cells, while the remaining cells downregulate c-kit
and CD44 and become DN3 cells. At the DN3 stage, proliferation is reduced and
the TCR β chain is expressed, forming the pre-T-cell receptor with the pre-Tα and
CD3. Formation of functional pre-TCR results in signalling that causes the cell
to stop β-chain rearrangement, allows TCR α chain rearrangement and triggers
differentiation to the CD4+CD8+ double positive (DP) stage of development. At
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the DP stage, both CD4 and CD8 are expressed, and the rearrangement and ex-
pression of the TCR α chain occurs152.
Following expression of a complete TCR αβ chain, thymocytes undergo thmyic
selection, a process where they interact with cells in the thymic epithelium to se-
lect for cells which express suitable TCRs to function as mature T-cells. If TCR
rearrangement does not produce functional TCR, a thymocyte may go through
several rounds of TCR α chain rearrangement and expression before either suc-
cessfully expressing a functional TCR or dying of neglect. The mechanisms which
control T-cell selection are complex, depending on the interaction of rearranged
TCR and the thymic environment.
During TCR selection cells undergo both positive and negative selection. In
positive selection, only cells which express a TCR capable of binding sufficiently
to MHC in the thymus survive to differentiate into single positive thymocytes.
Individual T-cells that survive selection and successfully engage MHC class I or
II will become CD8+ or CD4+ SP cells respectively. Mice incapable of producing
class I or class II MHC cannot produce SP CD8+ or SP CD4+ thymocytes re-
spectively180,181. Positive selection eliminates thymocytes which do not express
a functional TCR, or express a TCR with insufficiently strong binding to MHC;
this can be ∼90% of the thymocyte population.182 Key to the survival of thymo-
cytes is the orphan nuclear receptor RORγ, and members of the β-catenin sig-
nalling pathway (such as TCF-1), which regulate expression of the anti-apoptotic
factor Bcl-xL. Knockout of RORγ or TCF-1 results in increased levels of apop-
tosis in DP thymocytes and reduced levels of Bcl-xL183,184. The mechanisms by
which successfully selected TCRs recognise antigen/MHC as opposed to the self-
peptide/MHC which they are exposed to in the thymus is still not clearly un-
derstood, although there is some evidence that TCR binding during selection is
relatively promiscuous during TCR selection, and TCR binding in mature T-cells
is more selective185.
In negative selection, cells that bind too strongly to self-MHC undergo apop-
tosis, eliminating around half of the remaining, positively selected thymocytes.
This process was observed in thymocytes expressing the Vβ17a TCR segment:
Vβ17a+ cells were not present in the mature thymocyte population of mice ex-
pressing the class II MHC molecule IE, but were present in immature T-cells,
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indicating that some mechanism was eliminating those cells in a TCR-binding
dependent manner186. The mechanisms of positive selection remain unclear,
and several important questions remain, such as the role of co-receptors and the
mechanisms by which positively selecting TCR engagement is differentiated from
negatively selecting TCR engagement. It is thought that induction of negative se-
lection from TCR engagement occurs through a process of kinetic proofreading,
where not only is TCR engagement required, but ligands must remain bound for
sufficient time to allow full activation of the TCR pathways: this allows cells to
distinguish between a high concentration of low-avidity ligands and a low con-
centration of high-avidity ligands,169. Another key question in negative selection
is whether binding of a co-receptor such as CD28 is required. Knockout of CD28
and other coreceptors such as CD43 has little effect, although stimulation of these
receptors with antibodies results in increased apoptosis187.
Following successful TCR rearrangement and selection, remaining DP cells
further differentiate, first into CD4+CD8lo intermediates, then into CD4+CD8- or
CD4-CD8+ single positive (SP) T-cells, depending on which MHC class they are
capable of binding. The mechanisms by which TCR binding determines lineage
choice remains controversial, but it is known that CD4+ precursors upregulate
the transcription factors ThPok and cKrox188,189, while CD8+ cells upregulate
the RUNX family of proteins. These factors drive the silencing of CD8 and CD4
respectively, and differentiation into mature T-cells190. These cells then migrate
out of the thymus into the circulation, where they become mature naive T-cells,
and circulate between the blood and lymph systems.
1.3.3 MicroRNAs in T-cell development
MicroRNAs have been found to play a role at several stages of T-cell develop-
ment: studies using conditional Dicer-deleted mouse strains have observed the
effect of depleting miRNAs on thymic development, and found that deletion of
Dicer at the DN stage of development results in a significantly reduced thymic
population (∼tenfold fewer cells) mainly due to reduced survival of αβ lineage
T-cells. Despite this, surviving cells appear to undergo selection and lineage com-
mitment to CD4+ and CD8+ lineages normally.191.
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As well as investigations of the effect of Dicer deletions in T-cell development,
a number of studies have looked at the role of individual miRNAs in regulating
gene expression at particular stages of T-cell development. These have identified
a number of miRNAs which play a role in T-cell development and function. These
miRNAs include the miR-181 family, the miR-17-92 cluster and homologs, miR-
155 and miR-150.
1.3.3.1 The miR-181 family
One particularly well-characterised miR family in thymocyte development is the
miR-181 family, whose role in the immune system was first investigated when
it was found that overexpression of miR-181 in haematopoietic progenitor cells
produced a shift in lymphocyte towards the B-cell lineage192. This family, which
is made of miR-181 a, b, c and d, is expressed in three clusters: miR-181ab-1, miR-
181ab-2 and miR-181cd. Mir-181a and b have been found to be highly expressed
at the CD4+ CD8+ DP stage of thymocyte development, where they have been
shown to regulate a number of different targets, including the cell surface marker
CD69, anti-apoptotic protein Bcl-2, and the TCRα chain193. miR-181a has also
been shown to alter the sensitivity of thymocytes to TCR stimulation, potentially
by downregulating the phosphatases SHP2, PTPN2, DUSP5 and DUSP6, which
dephosphorylate components of the activation pathway, including Lck, ZAP70
and ERK 1/2194,195. This effect partially explains the increased sensitivity to TCR
activation that is observed in immature thymocytes196,197.
1.3.3.2 The miR-17-92 cluster
One of the first polycistronic miRNA transcripts identified, the miR-17-92 cluster
is made up of six miRNAs (miR-17, miR-18a, miR-19a, miR-20a, miR-19b, and
miR-92), and also has two additional homologous clusters: miR-106a-363 and
miR-106b-25. These clusters express many different miRNAs from four differ-
ent families (miR-17, miR-18, miR-19, and miR-25) and have been highly con-
served during vertebrate evolution198. The mir-17-92 cluster is ubiquitously ex-
pressed during lymphocyte development, but is downregulated on maturation.
Deletion of the miR-17-92 cluster is lethal, resulting in death shortly after birth
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from lung developmental defects. Investigation of immune development in miR-
17-92-deleted and Dicer-deleted mice observed that depletion of miR-17-92 pro-
duced a block in the pro-B to pre-B transition in immature B-lymphocytes199,200.
Subsequent studies have found that overexpression of the miR-17-92 cluster is
associated with increased proliferation and tumourogenic phenotypes in both T
and B cells, as well as eliminating the requirement for CD28 co-stimulation for
T-cell activation. This association with increased proliferation may be due to the
role of the miR-17-92 cluster in regulation of the tumour suppressor PTEN and
the anti-apoptotic protein Bim, and of several cell cycle regulators201,202.
1.3.3.3 miR-150
miR-150 is highly expressed in mature T and B cells, where is regulates the ex-
pression of the c-Myb transcription factor, which is expressed at high levels in
immature lymphocytes and downregulated on maturation. Deletion of miR-150
results in increased B-cell numbers, but also higher levels of c-Myb expression on
activation of CD4+ T-cells203,204.
1.3.3.4 miR-155
The miR-155 family of miRNAs has a wide range of functions in both the B and T-
cell lineages, as well as dendritic cells. Transcribed as part of the non-coding RNA
bic, miR-155 is found upregulated in activated B and T cells, as well as a number
of lymphomas. Deletion of miR-155/bic results in impaired immune response,
such as reduced production of interferon-γ and interleukin 2 in T-cells, as well
as a bias towards the Th-2 developmental pathway205,206 In B cells, miR-155 had
been found to target a number of factors, including the DNA mutator AID, and
the transcription factor PU.1, but it is not known what produces the phenotypes
seen in T-cells207–209.
1.4 Aims of this investigation
The principal aim of this study is to investigate the potential role of miRNAs
in regulating cell-cell variation. To this end, focusing on the well-characterised
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developmental system of the thymus, we use conditional Dicer knockout mice
to deplete miRNAs and single-cell methods to quantify the changes in gene ex-
pression and variation that result. To further characterise the system, we use
a combination of methods, including fluorescent reporter constructs, individ-
ual miRNA knockdown and miRNA profiling by RT-qPCR, to identify specific
miRNAs which may regulate noise and attempt to dissect the mechanisms by
which they act.
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2.1 Mice
Animal work performed in accordance with the Animals (Scientific Procedures)
Act, under project license 70/6845. LckCre Dicer∆/∆, cd4Cre Dicer∆/∆ and
Dicerlox/lox mice generously provided by B. Cobb191. C57Bl/6 mice and
C57Bl/6 Thy1.1+ mice provided by L. Bruno. Mir-181ab-1 knockout mice were
generously provided by Chang-Zheng Chen, and experiments using these mice
were performed in Stanford, USA under local animal regulations.
2.2 Cell culture
2.2.1 Primary cell culture
Unless otherwise stated, cell culture reagents were supplied by Gibco Invitro-
gen. Primary mouse thymocytes, peripheral T-cells and thymic reaggregates
were cultured at 37 °C in 5% CO2 in T-cell media: Iscove’s modified Dul-
becco’s medium (IMDM) supplemented with 10% foetal calf serum, penicillin
(100 U/ml)/streptomycin (100 µg/ml), 2 mM L-Glutamine and 50 µM 2-β mer-
captoethanol.
To create primary whole thymus and peripheral T-cell cultures, thymi or pe-
ripheral lymphoid organs (axillary, brachial, inguinal, cervical and mesenteric
51
2. MATERIALS & METHODS
lymph nodes) were dissaggregated in 10 ml T-cell media using a 2 ml syringe
plunger to pass cells through a 70 µm cell strainer. Subsequently, cells were cen-
trifuged at 240 g for 5 minutes and cell pellets were resuspended in 10 ml T-cell
media. Cells were counted using a haemocytomer and resuspended at an appro-
priate density for the required experiments.
2.2.2 Cell lines
293T cells (provided by L. Bruno) for retroviral production were grown in Dul-
becco’s Modified Eagle Medium (DMEM), supplemented with 10% foetal calf
serum, penicillin (100 U/ml)/streptomycin (100 µg/ml) , 2 mM L-Glutamine and
grown at 37 °C in 5% CO2. Cells were detached from the plate surface by pipet-
ting and split 1/10 every 2-3 days, to maintain an average cell density of 106
cells/ml.
2.2.3 Fetal thymic organ culture
Thymic stromal cells prepared by removing thymi from 14-16 day C57Bl/6 em-
bryos, separating thymi into individual thymic lobes using forceps, and incubat-
ing for 5-7 days on 0.8 µm nucleopore filters floating on T-cell medium (described
above) supplemented with 1.35 µM 2-deoxyguanosine (dGuo) to eliminate the
resident thymocytes. Following incubation, lobes were washed with PBS, pel-
leted by centrifugation at 240 g for 5 minutes, and then incubated for 30 min in
5 ml 0.05% trypsin-EDTA. Following trypsinisation, 2 ml FCS was added to neu-
tralise the trypsin, and the cells were then resuspended in 2 ml media and fully
dissaggregated by repeated pipetting. The resulting stromal cells were mixed
with experimental primary thymocytes in a ratio of 1:4 to respectively. The ag-
gregated cell mix was pelleted and the supernatant removed to produce a cell
slurry. The mix was pipetted onto a 0.8 µm nucleopore filter floating on T-cell
medium and incubated for 24 hours before disaggregation (using a 30G syringe),
cell surface staining, and analysis.
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2.2.4 T-cell activation
For thymocyte and peripheral T-cell activation with plate-bound anti-TCR anti-
body, Nunclon Delta flat-bottom plates were coated with anti-TCR antibody at
a concentration of 500 ng/ml in PBS unless otherwise stated, either overnight
at 4 °C or for four hours at 37 °C. These plates were then washed twice with PBS
(without Ca2+ or Mg2+) before cells were added. T-cells were added to the plates
at a density of 106 cells/ml unless otherwise stated, and were co-activated with
anti-CD28 antibody at a concentration of 2 µg/ml. Unless otherwise stated, cells
were then incubated for 18 hours at 37 °C in 5% CO2.
For retroviral infection, peripheral T-cells were activated with mouse
CD3/CD28 coated dynabeads (Invitrogen). 25 µl beads per 106 cells were washed
3 times with T-cell media and resuspended in 100 µl per 106 cells. Peripheral cells
were suspended at a density of 106 cells/ml and added to 24 well Nunclon plates,
1 ml per well. 100 µl washed beads were added to each well. Cells incubated for
18 hours at 37 °C in 5% CO2.
2.2.5 Retrovirus production and infection
293T cells were transfected with retroviral plasmids and packaging plasmids
pCL-Eco by CaCl2 precipitation
210. Briefly, DNA precipitated onto cells by addi-
tion of 500 µl fresh CaCl2 (0.4 M concentration, dissolved from solid CaCl2 fresh
for each experiment and sterilised by passing through a 0.45 µm syringe filter),
containing 4 µg of the packaging plasmid and 4 µg of the experimental plasmid,
to 500 µl HEBS (HEPES buffered saline): pH 7.05 buffer (280 mM KaCl, 10 mM
KCl, 1.5 mM Na2HPO4.2H2O, 2 mM glucose, 50 mM HEPES free acid). This mix
is added dropwise to 30% confluent 293T cells in 9 ml of 293T medium. 12 and
24 hours after transfection, media was removed and replaced with 10 ml fresh
293T media. At 36, 48 and 60 hours post-transfection, virus-containing media
was removed, stored at 4 °C, and replaced with fresh 293T media.
Thymocytes and peripheral T-cells were transduced with retrovirus by spin
infection211. Cells, in 24-well plates at a density of 106 cells/ml, were spun for 5
min at 240 g, media was removed and replaced with 1 ml viral supernatant per
well. Cells were centrifuged for 90 minutes at 900 g at 30 °C . After centrifugation,
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cells were incubated at 37 °C for 2 hours, then centrifuged to pellet cells (5 min at
240 g and room temperature (RT)), viral supernatant was removed, and cells were
resuspended in T-cell media. After infection, peripheral T-cells were incubated
at 37 °C for 48 hours, while thymocytes were used to create fetal thymic organ
cultures as described above.
2.2.6 Transfection of miRNA inhibitors
Both hairpin inhibitors (Dharmacon) and tiny LNA inhibitors (8 nt LNA oligonu-
cleotides complementary to the seed sequences of the miR-20, miR-181 and miR-
130 families212, purchased from Exiqon) were transfected into T-cells using Amaxa
nucleofector kits according to manufacturer’s protocols. Briefly, 5 million cells
were resuspended in 100 µl nucleofector transfection solution, inhibitors were
added at the required concentrations (0.5 µM or 10 µM for Dharmacon hairpin
inhibitors and tiny LNA inhibitors, respectively). Cells were electroporated us-
ing nucleofector programme X-01 using an Amaxa 3 machine and immediately
resuspended in pre-warmed 1.5 ml Amaxa T-cell Nucleofector medium. After 2
hours, cells were resuspended in T-cell media.
2.3 Flow Cytometry
2.3.1 Cell surface staining
Cells were stained using a number of fluorophore conjugated antibodies, as de-
scribed in the results, diluted as described in table 2.1. To stain cells, cells were
pelleted by centrifugation (320 g, 5 min, RT) and washed with FACS Buffer (PBS
from Gibco, supplemented with 5% FCS). Cells were then resuspended at a con-
centration of 4 × 106 cells/ml (for analysis) or 10 × 106 cells/ml for sorting in
FACS buffer containing staining antibodies and stained for 30 min at 4 °C. After
staining, cells were washed with FACS Buffer and analysed or sorted as required.
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2.3.2 Intracellular staining
Intracellular staining for phosphorylated ERK performed by 10 min fixation with
2% paraformaldehyde in RPMI medium at room temperature, followed by 1 hour
on ice in 90% methanol, added dropwise. All subsequent steps took place at 4 °C.
Following fixation, cells were rehydrated in FACS buffer containing phosSTOP
phosphatase inhibitors (Roche Applied Sciences, made up according to manu-
facturer’s instructions) for 20 min. Cells were washed with FACS buffer, then
stained for 45 min in FACS buffer with rabbit anti-ppERK antibody (as well
as additional fluorescently conjugated antibodies for cell surface markers), and
phosSTOP. Cells were washed in FACS buffer, then incubated with secondary
FITC-conjugated goat anti-rabbit antibody in FACS buffer with phoStop (See Ta-
ble 2.1 for full antibody details). Cells washed with FACS buffer and analysed.
2.3.3 Acquisition and analysis
Cells from both surface and intracellular staining were analysed with BD LSR II
or FACScalibur flow cytometers, or sorted with a BD FACSAria II or FACSAria
III cell sorter. Forward scatter (FSC) and side scatter (SSC) profiles were used to
identify live cells and doublet discrimination was performed using FSC-W/FSC-
A gating on LSR II and FACSAria machines. Fluorescence emission overlap be-
tween fluorophores was compensated by calibration of compensation parameters
with single-stained controls. Flow cytometry data was analysed using FlowJo
(Treestar). Further analysis for estimation of experimental noise was performed
using R213, and total least squares regression analysis of reporter construct ex-
pression was performed using MATLAB (The MathWorks, Inc).
2.4 Molecular biology
2.4.1 Primer design
For RT-qPCR primers, if validated primers were available for a given mRNA tran-
script from Primerbank (http://pga.mgh.harvard.edu/primerbank/), then these
were used; otherwise, primers were designed to amplify ∼150 nt exonic regions
55
2. MATERIALS & METHODS
of targeted transcripts using the Primer3 algorithm (http://frodo.wi.mit.edu/)
on default settings, with the exception of a minimum required primer length of
20 nt. All primers were tested using a serial dilution curve to ensure linear re-
sponse and primer amplification efficiency greater than 1.8.
2.4.2 Cloning
Dual Fluorescence (DF) constructs were created from pMSCVpuro plasmids from
Clontech. MonomericCherry (mCherry) sequence was generously provided by
N. Navaratnam and was amplified using primers containing HindIII and ClaI re-
striction sites. EnhancedGFP (eGFP) was cloned from MGIP plasmid provided
by B. Cobb, using primers with a BglII restriction site and a BamHI-Xho1-EcoR1
polylinker. 3’ UTR fragments were cloned from lymphocyte cDNA generated by
RT-PCR using SuperscriptIII (Invitrogen) following manufacturer’s instructions,
amplified using primers containing EcoR1 and Xho1 restriction sites. Site directed
mutagenesis (SDM) of the Cd69 3’ UTR carried out by two rounds of PCR, first
using the Cd69 3’ UTR primers and internal primers containing the mutation to
generate two partial fragments each containing the mutated site at one end, then
using a second round of PCR with the CD69 3’UTR primers to produce a full-
length fragment containing the mutation. All PCR reactions used Phusion DNA
polymerase (New England Biolabs) in a 50 µl reaction volume made up accord-
ing to manufacturer’s instructions, using the following PCR programme: 98 °C
for 30 s, then 35 cycles of 98 °C for 10 s, 55 °C for 30 s and 72 °C for 30s, with a
final step of 72 °C for 10 minutes. Following PCR, all fragments were gel puri-
fied, digested with appropriate restriction enzymes (New England Biolabs) using
manufacturer’s buffers and protocols and run on a low melting point agarose gel.
Vectors were dephosphorylated by addition of 1 µl calf intestinal phosphatase
(New England Biolabs) for 20 min at the end of restriction enzyme treatment.
Vectors were cut out of the gel and purified with a Qiagen gel purification kit.
Inserts were cut out of the gel and melted at 70 °C. 5 µl purified vector and 10 µl
melted insert were ligated using T4 DNA ligase (New England Biolabs). Ligated
product was transformed into competent DH5α E.coli by KCM transformation:
10 µl ligation mix added to 70 µl water and 20 µl KCM buffer (0.5 M KCl, 0.15 M
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CaCl2, 0.25 M MgCl2), 100 µl competent DH5α cells added. Cells cooled on ice
for 10 min, then incubated at RT for 10 min. 500 µl LB broth (Sigma-Aldrich) (con-
taining 50 µg/µl ampicillin (Sigma-Aldrich)) added, and cells were incubated at
37 °C for 30 min and then 50 ul of mix was plated onto LB-agar plates (1.5%
(w/v) bacto agar (Merk) in LB broth (supplemented with ampicillin as above)),
and incubated overnight at 37 °C. Colonies were picked into 5ml LB broth (sup-
plemented with ampicillin), incubated overnight at 37 °C and DNA minipreps
of the colonies were purified using Qiagen QiaPrep kits, screened by restriction
enzyme digestion and sequenced by the MRC CSC Genomics Core Facility to
ensure correct insertion.
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Figure 2.1: Dual fluorescence reporter vector - Map of Dual Fluorescence reporter
vector, showing important sequences and significant restriction sites
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2.4.3 RNA extraction
Whole RNA fractions were extracted using RNA-Bee isolation reagent (AmsBio),
according to manufacturers protocols. Small RNAs were isolated using MirVana
miRNA isolation kit, following manufacturer’s protocol, isolating separate small
and large RNA fractions, and eluting in 50 µl RNAse-free water. RNA yield was
measured using a Nanodrop machine (Thermo Scientific).
2.4.4 Real-Time PCR
Any residual DNA was digested with Turbo DNAse (Ambion), and RNA was
reverse transcribed with SuperscriptIII (Invitrogen) following manufacturer’s in-
structions. Real-time PCR analysis of mRNA levels was carried out on a Chromo4
DNAengine machine running Opticon 3 software. Template cDNA was diluted
× 10 and 2 µl of diluted template was added to 10 µl iQ SYBR Green Supermix
(Biorad) and 0.6 µl primers at 10 µM concentration in a total reaction volume of 20
µl. The PCR program used was 95 °C for 3 minutes, then 40 cycles of 94 °C for 15
s, 60 °C for 30 s and 72 °C for 30 s. All experiments were conducted in duplicate,
with a blank control for each primer pair. For each experiment, a melting curve
between 70 °C and 95 °C was run to ensure consistent annealing. Transcript lev-
els were calculated by the ∆∆CT method and normalised to expression of Hprt.
All primers are listed in table 2.2.
For RT-qPCR of small RNAs, small RNA samples were reverse transcribed us-
ing Taqman miRNA-specific primers and RT kits (all from Applied Biosystems).
3 µl template RNA was added to 6.16 µl RNA-free water, 1 µl Multiscribe re-
verse transcriptase, 1.5 µl 10 × Multiscribe buffer, 0.15 µl 100 mM dNTPs, 0.19
µl RNAse inhibitors and 3 µl miRNA-specific primers. Mix was incubated at 16
°C for 30 min, 42 °C for 30 min, and 85 °C for 5 min. For qPCR, 1.35 µl template
cDNA was added to 10 µl Taqman mastermix, 1 µl miRNA-specific probe and
7.65 µl water in a total reaction volume of 20 µl. The PCR programme used was
95 °C for 10 minutes, followed by 40 cycles of 95 °C for 15 s and 60 °C for 1 min.
All experiments were conducted in triplicate, with a blank control of each probe.
Relative levels of miRNAs calculated using the ∆∆CT method, normalising to
the geometric average of housekeeping small nucleolar RNAs snoRNA-135 and
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snoRNA-202. For copy number calculations, standards of known concentration
were also run alongside experimental samples, and for each experiment, a re-
gression line was plotted to allow conversion of CT values into copy numbers for
specific miRNAs.
2.4.5 Western blotting
One million cells from each sample were lysed by briefly vortexing and incu-
bating for 5 minutes at 95 °C in 100 µl sample buffer (0.05 M Tris pH 6.8, 2%
Sodium dodecyl sulfate (SDS), 20% glycerol, 0.001% bromophenol blue and 5%
beta-mercaptoethanol) and loaded on an SDS-polyacrylamide gel, consisting of a
10% separating gel (10% acrylamide, 0.4 M Tris pH 8.8, 0.1% SDS, 0.05% ammo-
nium persulfate (APS), 0.1% N, N, N’, N’ -tetramethylethylenediamine (TEMED))and
a 4% stacking gel (4% acrylamide, 0.125 M Tris pH 6.8, 0.1% SDS, 0.0667% APS,
0.12% TEMED) along with Benchmark prestained protein ladder (Invitrogen) for
molecular weight reference. Gels were run in running buffer (25 mM tris base,
192 mM glycine, 0.1% SDS) on a Bio-Rad minigel system for 1 hour at 30 mA.
Following successful electrophoresis, gels were transferred to Milipore
Immobilon-FL PVDF membrane. Membranes were pre-treated for 30 s in 100%
methanol, 5 minutes in distilled water, and 5 minutes in transfer buffer (48 mM
Tris base, 39 mM Glycine, 0.037% SDS, 20% methanol), then assembled with the
separating portion of the gel between two layers of Whatmann paper in a Trans-
Blot SD Semi-Dry Electrophoretic Transfer Cell (Bio Rad). The cell was run for 75
minutes at 140 mA.
Membranes were blocked with 5% bovine serum albumin (Sigma-Aldrich)
dissolved in wash buffer (150 mM NaCl, 10 mM tris base) for 30 min, then stained
overnight at 4 °C with anti-ppERK antibody (see table 2.1) dissolved in wash
buffer supplemented with 5% bovine serum albumin. After primary staining,
membrane was washed three times with wash buffer and secondary staining was
performed for 30 min with rabbit anti-goat antibody (see table 2.1) conjugated to
Alexa Fluor 680. Following staining, membrane was washed three times with
wash buffer and imaged on an Odyssey 2 luminometer. After ppERK staining,
cells were stained for 2 hours with anti-lamin B (see table 2.1) as a loading control,
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washed 3 times with wash buffer, secondary stained for 30 minutes with donkey
anti-goat antibody (see table 2.1) conjugated with Alexa Fluor 680, washed three
times with wash buffer and imaged on an Odyssey 2 luminometer (LI-COR Bio-
sciences).
2.5 Computational simulation
Simulations of transcriptional networks were carried out using the Gillespie ex-
act stochastic simulation algorithm8, programmed and analysed using R213. See
Appendix 1 for example code. Simulation times were determined by running
test simulations and observing the time required to reach an approximate steady
state: subsequent simulations were run for at least double this time to ensure the
systems are close to a steady state when observations were recorded.
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Target Application Clone Conjugation Host Supplier Dilution
Mouse TCR T-cell activa-
tion
H57-597 None Armenian
Hamster
BD Pharmingen (see
results)
Mouse CD28 T-cell activa-
tion
37.51 None Syrian
Hamster
BD Pharmingen 1/500
Mouse CD4 FACS staining RM4-5 PerCP Rat BD Pharmingen
or Biolegend
1/100
Mouse CD4 FACS staining RM4-5 Pacific Blue Rat BD Pharmingen
or Biolegend
1/400
Mouse CD8a FACS staining 53-6.7 APC Rat BD Pharmingen
or Biolegend
1/400
Mouse CD8a FACS staining 53-6.7 APC-Cy-7 Rat BD Pharmingen
or Biolegend
1/400
Mouse CD8b FACS staining 53-5.8 FITC Rat BD Pharmingen 1/400
Mouse CD25 FACS staining PC61 PE Rat BD Pharmingen
or Biolegend
1/400
Mouse CD69 FACS staining H1.2F3 FITC Armenian
Hamster
BD Pharmingen
or Biolegend
1/200
Mouse CD44 FACS staining IM7 FITC Rat BD Pharmingen
or Biolegend
1/200
Mouse Sca-1 FACS staining E13-161.7 FITC Rat BD Pharmingen
or Biolegend
1/200
Mouse THY1.1 FACS staining OX-7 FITC Rat BD Pharmingen 1/200
phospho-ERK FACS stain-
ing, western
blotting
D13.14.4E None Rabbit Cell Signalling
Technologies
1/1000
Anti-rabbit IgG FACS staining Polyclonal FITC Goat Santa Cruz
Biotechnology
1/100
Mouse LAMIN B Western blot-
ting
Polyclonal None Goat Santa Cruz
Biotechnology
1/20000
Anti-rabbit IgG Western blot-
ting
Polyclonal Alexa Fluor
680
Goat Invitrogen 1/2000
Anti-goat IgG Western blot-
ting
Polyclonal Alexa Fluor
680
Donkey Invitrogen 1/2000
Table 2.1: Antibodies
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Cloned Sequence Forward Reverse
mCherry ATCATCAAGCTTGTCGCCA-
CCATGGTGAGCAAGGGCG-
AGGA
TCCGAAATCGATCTACTTG-
TACAGCTCGTCCATGC
eGFP CATCAGATCTCAATTGGCG-
GCCGCACAACCATGGTGA-
GCAAGGGCGAGGA
ATCATCGAATTCGTTAACC-
TCGAGGGATCCTTACTTGT-
ACAGCTCGTCCA
Cd69 3’ UTR AAAAAACTCGAGCGAGGA-
TACATAGATGTATA
CATCATGAATTCGCACATG-
GGAAATATTTTGG
Cd44 3’ UTR ATCATCCTCGAGTGCCTAC-
GCCATTAACTTGA
ATCATCGAATTCAATGAGA-
TTGAGCTGGGTGAA
Sca-1 3’ UTR ATCATCCTCGAGTGGTCCT-
CCCAATGACCTCC
GATGATGAATTCGGACTCA-
ACAGGGGGACATT
Cd69 3’ UTR miR-
181 SDM 1
AAAAAACTCGAGCGAGGA-
TACATAGATGTATA
TCCTGTACCTATTCCAAGCT-
CTTCCTA
Cd69 3’ UTR miR-
181 SDM 2
TAGGAAGAGCTTGGAATA-
GGTACAGGA
CATCATGAATTCGCACATG-
GGAAATATTTTGG
Cd69 3’ UTR miR-
130 SDM 1
AAAAAACTCGAGCGAGGA-
TACATAGATGTATA
CTTTACGCATTATTGCCATT-
TGGAGGGG
Cd69 3’ UTR miR-
130 SDM 2
CCCCTCCAAATGGCAATAA-
TGCGTAAAG
CATCATGAATTCGCACATG-
GGAAATATTTTGG
Cd69 3’ UTR miR-
20 SDM 1
AAAAAACTCGAGCGAGGA-
TACATAGATGTATA
TAAAAAAAAATGACTAAG-
GTTGATGAGG
Cd69 3’ UTR miR-
20 SDM 2
CCTCATCAACCTTAGTCAT-
TTTTTTTTA
CATCATGAATTCGCACATG-
GGAAATATTTTGG
Cd69 3’ UTR 0-610
truncation
AAAAAACTCGAGCGAGGA-
TACATAGATGTATA
ATCATCGAATTCAGGTTTTT-
AAAGGTTAAGAA
Cd69 3’ UTR 0-410
truncation
AAAAAACTCGAGCGAGGA-
TACATAGATGTATA
ATCATCGAATTCAAAATCA-
TTAATCAGTCAAA
Cd69 3’ UTR 210-
820 truncation
ATCATCCTCGAGAACTGAC-
TGCTAATCACATC
CATCATGAATTCGCACATG-
GGAAATATTTTGG
Cd69 3’ UTR 410-
820 truncation
ATCATCCTCGAGTTTGACT-
GATTAATGATTTT
CATCATGAATTCGCACATG-
GGAAATATTTTGG
Table 2.2: Cloning primers
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Transcript
Name
Forward Reverse
Cd69 CCTTGGCCCAACGCTCTTGT-
T
TGCCTCACAGTCCACAGCG-
GTA
Hprt AGTCCCAGCGTCGTGATTA-
GCG
TAGCCCCCCTTGAGCACAC-
AGA
Cd44 ATAGTAGGAGAAGGTGTG-
GG
GTCTCTGATGGTTCCTTGTT
Sca-1 AGGAGGCAGCAGTTATTGT-
GG
CGTTGACCTTAGTACCCAG-
GA
Table 2.3: RT-qPCR primers
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3Dicer deletion results in increased
cell-cell variation in specific genes
3.1 Cd44 and Sca-1 show developmentally regulated
expression
Previous experimental analysis has shown that miRNAs play important roles in
T-cell development191,193,214. In particular, microarray comparison of transcript
levels between wild-type and Dicer-deleted DP thymocytes showed significant
changes, particularly upregulation, in the expression of many genes, suggesting
a large number of transcripts are regulated by miRNAs. Bioinformatic compari-
son of these upregulated transcripts with developmental gene expression profil-
ing data found that upregulated transcripts were enriched in genes which are
differentially expressed during thymocyte development, and that these genes
were enriched for 3’ UTR sequences containing binding sites for a number of
miRNAs, particularly the miR-181 and miR-17 families, suggesting that miRNA-
mediated regulation plays a significant role in regulating the expression of these
transcripts215. From these data, we chose a number of genes to further investigate
at the single cell level, based on availability of reliable antibodies for quantitative
flow cytometry. In particular, we looked at the expression of cell surface proteins
CD44, a protein involved in cell-cell interactions and cell migration, and Sca-1
(also known as LY6A), a marker of stem-cell and haematopoietic development
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(see Introduction). We validated that these genes show differential regulation
during thymocyte development by sorting cell populations from thymii and pe-
ripheral lymphoid organs from wild-type (WT) C57Bl/6 mice into DN, CD4+
CD8+ DP, CD4+ SP, peripheral CD4+ and peripheral CD8+ stages of T-cell de-
velopment, and quantifying mRNA expression by RT-qPCR. Both our genes of
interest show an increase in gene expression as cells mature from the DP to the
CD4+ SP stage of T-cell development (Figure 3.1).
CD4 + CD8 + DP 
DN CD4 + SP
CD4 + Peripheral
CD8 + Peripheral
mRNA expression 
Cd44
Sca-1
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
Figure 3.1: Cd44, Sca-1 and Cd69 show differential expression patterns during T-
cell development - Expression of Cd44, Sca-1 and Cd69 determined by RT-qPCR in
CD4- CD8- DN, CD4+ CD8+ DP, CD4+ SP and peripheral CD4+ and CD8+ cells
sorted by flow cytometry. Expression was normalised to Hprt and scaled so that the
maximum expression of each gene was 1. Error bars show standard error calculated
from 3 biological replicates.
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3.2 CD44 and Sca-1 protein expression is deregulated
in Dicer-depleted thymocytes
To investigate the role of miRNAs in the regulation of the robustness of develop-
mental pathways in T-cells, we used Dicerlox/lox mice191 containing LoxP sites
flanking the RNAse III domain of Dicer, which is required for mature miRNA
production. To deplete miRNAs at specific stages of development, these mice
were crossed with strains expressing the Cre recombinase under the control of a
developmental-stage specific promoter. In particular, lckCre Dicer lox/lox mice
which have both the lox-flanked Dicer allele and Cre under the control of the Lck
promoter, which is expressed at the DN stage of thymocyte development, showed
a depletion of ∼90% of mature miRNAs in DP thymocytes191. Similarly, to look
at later stages of T-cell development, Cre expressed under the control of the CD4
promoter can deplete miRNAs after the DP stage of development214.
To look at potential deregulation of transcripts, we analysed expression of
CD44 and Sca-1 in TCRlow CD4+ CD8+DP thymocytes by flow cytometry, which
allows the observation of protein expression in single cells across a population.
Gating for the large population of TCRlow DP thymocytes allowed us to analyse
the large, homogenous population of pre-selection DP thymocytes, to ensure that
expression of our genes of interest was not affected by thymic selection. Compar-
ison of histograms of CD44 and Sca-1 expression in populations of Dicerlox/lox
and lckCre Dicer∆/∆ cells shows a clear increase in protein expression compared
with other cell surface markers such as LY6C (Figure 3.2).
Mean expression data from these histograms was calculated and pooled, show-
ing a median increase in Sca-1 expression of 90% and a median increase of CD44
expression of 50% in miRNA-depleted cells, consistent with miRNA-dependent
regulation of these transcripts (Figure 3.3) expression of the control LY6C showed
an increase in expression of less than 4%.
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Figure 3.2: Sca-1 and CD44 proteins show changes in the distribution of protein
expression in populations of Dicer-deleted thymocytes - (a) Typical flow cytometry
histogram showing gating for TCRlow populations. (b-d) Typical flow cytometry
expression histograms of (b) Sca-1, (c) CD44 and (d) LY6C in Dicerlox/lox (black) and
lckCre Dicer∆/∆ (red) TCRlow DP mouse thymocytes. Histograms are normalised
to the total size of each population. Mean and CV of each population inset in plot.
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Figure 3.3: Sca-1 and CD44 proteins show increased mean expression in Dicer-
depleted thymocytes - Box-and-Whiskers plots showing the distribution of mean
protein expression of (a) Sca-1, (b) CD44 and (c) LY6C in Dicerlox/lox (black) and
lckCre Dicer∆/∆ (red) CD4+ CD8+ DP TCRlow thymocytes, analysed by flow cy-
tometry. Data are normalised to mean expression of each protein in Dicerlox/lox
cells. Figures show pooled data from between 10 and 30 biological replicates, incor-
porating some data from M. Merkenschlager
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3.3 Correlation of protein and mRNA levels
Although RT-qPCR-based measures of mRNA levels can only measure the aver-
age mRNA level over a population, we could check whether mRNA levels corre-
lated with protein levels as recorded by flow cytometry by sorting DP thymocytes
by expression of CD44 or Sca-1 into populations expressing high or low levels of
these proteins. Levels of mRNA in these populations were assayed by RT-qPCR
and were found to be consistent with the results obtained through flow cytom-
etry: cells expressing high levels of protein also express higher levels of mRNA
than cells expressing low levels of protein, and miRNA-depleted cells in both
populations express higher levels of mRNA, consistent with relief of miRNA-
mediated repression (Figure 3.4).
3.4 CD44 and Sca-1 show increased cell-cell variation
in Dicer-deleted thymocytes
Interestingly, as well as an increase in mean levels of gene expression, flow cy-
tometry histograms of Sca-1 and CD44 showed a noticeable increase in the width
of the flow cytometry peaks (Figure 3.2). This suggests that deletion of Dicer re-
sults in an increase in cell-cell variation. For accurate investigation of the effect
of miRNAs on gene expression and on cell-cell variation in gene expression, we
needed to be able to quantify protein expression at a single-cell level to enable
us to get an accurate snapshot of the distribution of protein expression across a
population of cells, and calculate from this population data a measure of cell-cell
variation. Flow cytometry observation of protein expression across a population
has the required single-cell resolution, but to quantify variation in protein expres-
sion several different measures could be used: the simplest, and most common
measure of population variation is the standard deviation, but other possible
measures of variation are the coefficient of variation (CV) or the noise strength
(see Introduction).
The coefficient of variation was used, as, under the circumstances of miRNA
depletion, it is the most stringent measure of an increase in noise: i.e. if an in-
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Figure 3.4: Sca-1 and Cd44 mRNA and protein levels show similar responses to
Dicer-depletion - mRNA levels of (a) Sca-1 and (b) Cd44 mRNA determined by RT-
qPCR in Dicerlox/lox (black) and lckCre Dicer∆/∆ (red) thymocytes sorted by flow
cytometry for CD4+ CD8++ DP TCRlow populations expressing high and low lev-
els of Sca-1 or CD44, respectively. Lower flow cytometry histograms show typical
protein expression and gating, normalised by the size of each population. Transcript
expression levels normalised to Hprt and shown relative to the Dicerlox/lox cells low
protein expression sample for each protein. Error bars indicate standard error from
three independent replicates.
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crease in the CV is observed at the same time as an increase in mean protein
expression (which would be expected in knockdown of a miRNA which both re-
presses a gene, and regulates its variation), both the standard deviation and the
noise strength will also have increased. The reverse is not true: if an increase in
the standard deviation or the noise strength is observed at the same time as an
increase in the mean expression of a protein, this could be because of a change in
variation due to miRNA regulation, or it could be because the standard deviation
increases proportionally with the mean expression. Thus, under our experimen-
tal protocols, an increase in both mean expression and CV would unambiguously
indicate an increase in cell-cell variation by any of these measures of noise.
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Figure 3.5: Sca-1 and CD44 proteins show increased CV in Dicer-depleted thymo-
cytes - Box-and-Whiskers plots showing the distribution of the CV of (a) Sca-1, (b)
CD44 and (c) LY6C in Dicerlox/lox (black) and lckCre Dicer∆/∆ (red) CD4+ CD8+
DP TCRlow thymocytes, analysed by flow cytometry. Data are normalised to the CV
of gene expression in Dicerlox/lox cells. Figures show pooled data from between 10
and 30 biological replicates, incorporating some data from M. Merkenschlager
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Calculating the CV of Sca-1 and CD44 protein expression across populations
of DP thymocytes, a clear increase in CV relative to wild-type thymocytes can be
observed. In CD44 this shows a median increase of 30% over the CV of wild-type
populations; in Sca-1 expression, a median increase of 15% is observed; a median
increase of 4% is seen in the LY6C control (Figure 3.5).
3.5 Estimation of experimental noise
For these measurements of CV in CD44 and Sca-1 to be an accurate measures of
biological cell-cell variation, we must also estimate the experimental noise ie. the
variation attributable to the experimental techniques, such as variations in fluo-
rescence measurements. We followed a similar procedure to that used in a recent
study216 and stained DP thymocytes for CD8α and CD8β chains, which are ex-
pressed at a 1:1 stoichiometry. By measuring the CV in the ratio between the two
subchains, an upper bound for the experimental noise can be obtained, as the
measured noise will be a combination of biological variation in the CD8α:CD8β
ratio, which is low, and experimental noise from factors such as autofluorescence,
incomplete antibody binding and measurement error in the flow cytometer. In
our experiments, this was approximately 20% (Figure 3.6). This compares with
measurements of CVs in our experimental systems, which are typically around
30-60%. Dicerlox/lox and lckCre Dicer∆/∆ cells show similar estimates of exper-
imental noise, as would be expected if the noise in our estimates are largely due
to non-biological sources.
3.6 Depletion of miRNAs results in increased CD69
expression and variation in activated thymocytes
Another candidate miRNA-regulated protein was also investigated, CD69: a cell-
surface marker known primarily as a marker of early T-cell activation. Little is
known about CD69 function in T-cells, but it is thought to have a role in cell sig-
nalling and cell migration172. CD69 has been identified as a deregulated gene in
Dicer∆/∆ thymocytes, and previous studies have also identfied it as a miRNA
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Figure 3.6: Estimation of experimental noise - Typical flow cytometry plots of DP
Thymocytes from a) Dicerlox/lox and b) lckCre Dicer∆/∆ cells costained for CD8α
and CD8β chains. c) Histogram of CD8α/CD8β ratio in Dicerlox/lox (black) and
lckCre Dicer∆/∆ DP thymocytes, normalised by the size of each population. Experi-
mental noise estimated by calculating the CV of this ratio.
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target of the miR-181 family of miRNAs193. CD69 is particularly interesting, be-
cause, in addition to a low level of basal expression during thymocyte develop-
ment, CD69 expression is upregulated shortly after T-cell activation. For example,
activation of thymocytes with increasing concentrations of plate-bound anti-TCR
antibody, coupled with costimulation by soluble anti-CD28 antibody, results in
an increasing proportion of activated cells marked by high CD25 and CD69 ex-
pression (Figure 3.7a). CD69 upregulation also shows a bimodal "all-or-nothing"
response, being expressed at either low levels in unactivated cells or high levels
in activated cells, with very low levels of intermediate levels of expression (Figure
3.7b). CD69 is both a miRNA target and highly regulated during T-cell activation,
making it a potential candidate for involvement in a miRNA-containing FFL dur-
ing activation.
To look at CD69 expression during T-cell activation, we created whole-
thymocyte primary cultures, and activated them with varying concentrations of
plate-bound anti-TCR antibody, costimulating with soluble anti-CD28 (2 µg/ul)
for 18 hours. While this system is somewhat artificial compared to the thymic
environment, it is highly consistent, showing a saturation curve with maximum
stimulation using 500 ng/ml anti-TCR antibody, and reduces the possibility of
additional experimental noise caused by changes in the activatory stimulus. Acti-
vated cells were identified by gating for CD25+ CD69+ cells. Deletion of Dicer re-
sults in a ∼50% increase in mean levels of CD69 expression, relative to wild-type
Dicerlox/lox cells, in CD4+ SP cells after activation with a range of concentra-
tions of anti-TCR antibody (Figure 3.7c). As with CD44 and Sca-1, we also looked
at changes in CD69 CV in lckCre Dicer∆/∆ relative to Dicerlox/lox cells: CD69
CV shows a increases of ∼20% in lckCre Dicer∆/∆ cells (Figure 3.7c). To further
investigate this, we looked at DP and CD4+ SP thymocytes and CD4+ peripheral
T-cells after 18 hours of activation with 500 ng/ml anti-TCR antibody. Similarly to
CD44 and Sca-1, flow cytometry histograms in activated (CD25+ CD69+) lckCre
Dicer∆/∆ thymocytes showed both higher expression and a broader histogram
peak, consistent with miRNA regulation of both CD69 mean expression and cell-
cell variation in CD69 levels (Figure 3.8). Interestingly, this Dicer-dependent regu-
lation of CD69 noise appears to occur only at specific stages of development: un-
like in thymocytes, CD69 expression in activated peripheral CD4+ T-cells shows
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Figure 3.7: Activation of CD4+ SP thymocytes by anti-TCR antibody - (a) Typical
CD69 and CD25 density plots after 18 hours’ activation of CD4+ thymocytes with
anti-TCR antibody at the stated concentrations. Cells also costimulated with anti-
CD28 antibody at 2 µg/ml. Percentages indicate percentage of activated (CD25+
CD69+) CD4+ cells. (b) Representative histograms showing effect of 18 hours’ ac-
tivation with increasing concentrations of plate-bound anti-TCR antibody on CD69
CV in CD4+ SP thymocytes. Cells also costimulated with anti-CD28 antibody at
2µg/ml. (c-d) Effect of increasing concentrations of plate-bound anti-TCR antibody
on (c) mean CD69 levels and (d) CV of CD69 expression in activated (CD25+ CD69+)
CD4+ Dicerlox/lox (black) and lckCre Dicer∆/∆ (red) cells after 18 hours’ activation.
Mean and CV values normalised to 500 ng/ml Dicerlox/lox mean and CV respec-
tively. Cells also costimulated with anti-CD28 antibody at 2µg/ml. Error bars show
standard error from four experiments.
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Figure 3.8: Expression pattern of CD69 in activated thymocytes - Typical histograms
of CD69 expression in activated (a) DP (b) CD4+ SP and (c) peripheral CD4+ cells.
Dicerlox/lox (black) and lckCre Dicer∆/∆ cells activated with anti-TCR (500 ng/ml)
and costimulated with anti-CD28(2 µl/ml) for 18 hours and gated for activated
CD25+ CD69+ cells.
a clear increase in expression, but no increase in cell-cell variation.
To quantify these changes in expression, we pooled mean CD69 expression
levels and CVs of CD69 from multiple experiments. Analysis of the mean level
of CD69 expression in activated DP thymocytes, CD4+ SP thymocytes and pe-
ripheral CD4+ T-cells showed median increases of 56%, 53% and 40% , respec-
tively, in CD69 expression in Dicer∆/∆ cells over Dicerlox/lox cells (Figure 3.9a-
c), supporting our observations of a strong increase in CD69 expression at all
three stages of T-cell development investigated. Pooling data on the CVs of CD69
expression in activated thymocytes showed increases in CD69 CV of 56% and
30% in activated DP and CD4+ SP thymocytes respectively, but a small decrease
in CD69 CV in activated CD4+ SP peripheral T-cells(Figure 3.9d-f). This suggests
that while CD69 expression is regulated by miRNAs at all stages of development
that were analysed, the changes in CD69 noise we observed appear only in im-
mature thymocytes.
To confirm that changes in CD69 expression were due to the depletion of
miRNAs, a number of important controls were required: firstly, we checked that
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Figure 3.9: MicroRNA-depleted thymocytes show increased CD69 mean expres-
sion and CV on activation - (a-c) Box-and-whiskers plots showing change in mean
CD69 expression in activated (with 500 ng/ml anti-TCR and 2 µg/ml anti-CD28
antibodies) lckCre Dicer∆/∆ CD25+ T-cells (red) from (a) DP cells, (b) CD4+ SP
cells and (c) CD4+ peripheral T-cells, relative to Dicerlox/lox T-cells (black). Mean
CD69 expression is normalised to mean expression in Dicerlox/lox cells. (d-f) Box-
and-whiskers plots showing change in CV of CD69 expression in activated lckCre
Dicer∆/∆ CD25+ T-cells (red) from (a) DP cells, (b) CD4+ SP cells and (c) CD4+ pe-
ripheral T-cells, relative to Dicerlox/lox T-cells(black). CD69 CVs are normalised to
mean CVs in Dicerlox/lox cells. Plots show pooled data from 46 biological replicates
in thymocytes and 12 biological replicates in peripheral T-cells. Plots incorporate
some data from M. Merkenschlager.
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the expression of the Cre recombinase is not causing abnormal gene expression
and additional noise by repeating the activation experiments using lckCre thy-
mocytes as controls, instead of Dicerlox/lox cells.
Comparison of activated lckCre and lckCre Dicer∆/∆ thymocytes showed
similar patterns in mean expression and CV of CD69. DP thymocytes show a
median increase of ∼2.5-fold in mean CD69 expression, and a median increase of
40% in CD69 CV. CD4+ SP thymocytes show a median increase of 40% in mean
CD69 expression and an increase of 24% in CD69 CV (Figure 3.10). These results
indicate that the Dicer-dependent increases in mean and CV of CD69 expression
observed in activated cells are not a product of lckCre expression alone.
It has been previously reported that lckCre Dicer∆/∆ thymocytes are more
susceptible to cell death191,215. To check that changes in variation in gene expres-
sion observed in Dicer-depleted cells were not due to selective death of lckCre
Dicer∆/∆ thymocytes during activation, we mixed lckCre Dicer∆/∆ cells and
wild-type C57 BL/6 Thy1.1+ cells in culture, and activated them for 18 hours
with anti-TCR and anti-CD28 antibodies. After activation, cells were stained and
analysed using flow cytometry, using staining for Thy1.1 to distinguish the two
populations, and detect changes in the relative ratios of the C57Bl/6 and lckCre
Dicer∆/∆ cells on activation, allowing the detection of any significant increase
in cell death in Dicer∆/∆ cells . Analysis of these ratios showed no significant
change in the relative numbers of WT and Dicer∆/∆ cells, suggesting that acti-
vation of thymocytes does not result in selection for a particular population of
cells(Figure 3.11).
Deletion of the Dicer RNAse III domain does not completely deplete cells of
mature miRNAs, typically reducing miRNA expression to 10% of previous lev-
els191. It is possible that observed populations of Dicer-deleted thymocytes may
actually contain a small population of cells which express WT levels of miRNAs.
If this is the case, and if WT and miRNA-depleted thymocytes express CD69 at
different levels, our observations of miRNA-depleted cells could actually be ob-
servations of the addition of two populations (a large Dicer-deleted population,
and a residual population of WT cells), which have the same CV but different lev-
els of mean expression, and the addition of these two populations might result
in a combined population with a larger CV. To check that the increase in CV ob-
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Figure 3.10: Expression of Cre recombinase is not responsible for changes in CD69
expression - (a) Relative mean expression of CD69 in activated (with 500 ng/ml anti-
TCR and 2 µg/ml anti-CD28 antibodies) DP thymocytes (b)Relative CV of CD69
expression in activated DP thymocytes (c) Mean expression of CD69 in activated
lckCre and lckCre Dicer∆/∆ CD4+ thymocytes (d)Relative CV of CD69 expression in
activated lckCre and lckCre Dicer∆/∆ CD4+ thymocytes. All results normalised to
the mean of the lckCre measurements. Plots show pooled results from 10 replicates.
Error bars show minimum and maximum values.
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Figure 3.11: Thymocyte activation does not select for or against lckCre Dicer∆/∆
thymocytes - Thymocytes from Thy1.1+ and lckCre Dicer∆/∆ mice mixed at a 1:1 ra-
tio and activated with anti-TCR (500 ng/ml) and anti-CD28 antibodies for 18 hours.
After activation proportion of Thy1.1+ and lckCre Dicer∆/∆ cells determined by gat-
ing CD4+ CD8+ DP and CD4+ SP populations on Thy1.1 expression. Graphs show
percentages of (Thy1.1+) and lckCre Dicer∆/∆ at each stage of development. Error
bars show standard error from three independent experiments.
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served is not due to a residual population of miRNA expressing wild-type cells,
in silico experiments were performed to mix Dicerlox/lox and lckCre Dicer∆/∆
CD4+ SP thymocyte populations, activated for 18 hours with anti-TCR and CD28
antibodies, recorded from earlier experiments, and to measure the effect on the
CV of CD69 expression observed. A varying percentage of Dicerlox/lox cells
were added to a fixed population of lckCre Dicer∆/∆ cells, and the CV of the
resulting mix was calculated, and averaged across data from 10 different exper-
iments. Addition of a population of Dicerlox/lox cells results in at most an in-
crease in CV of 1%, compared to a typical increase in CV of 30% in activated
CD4+ SP thymocytes (Figure 3.12a).
However, our data from lckCre Dicer∆/∆ cells may already contain a small
population of miRNA-expressing cells, which could mask any increase in CV
that would be produced by computational addition of more miRNA-expressing
cells. To address this issue, cells were computationally removed from an exper-
imentally recorded population of Dicer-depleted cells, following the distribution
of Dicerlox/lox cells, and the effect on CD69 CV was observed. Subtracting pop-
ulations resulted in a decrease in CV, which would be consistent with a hidden
population of miRNA-expressing cells increasing the observed CV; however, the
changes in CV observed were substantially smaller than those seen experimen-
tally: to produce a 5% increase in CV, the hidden miRNA-expressing population
would have to comprise over 40% of the total cells, which would not produce
the 90% reduction in miRNA levels previously observed(Figure 3.12b). Neither
adding nor removing WT cells from our miRNA-depleted cells affected the CV
in the manner seen experimentally: these results show that increases in CD69 CV
observed are not readily accounted for by residual Dicer-expressing cells.
Finally, we investigated to what extent deletion of Dicer affects the upstream
pathways of T-cell activation, in particular, the ERK pathway, which is one of
the principal drivers of activation-induced CD69 expression171 and could con-
tain upstream miRNA targets, which might produce changes in CD69 expression
in Dicer-deleted cells. To quantify ERK pathway activation at the single-cell level
we fixed Dicerlox/lox and lckCre Dicer∆/∆ whole thymus populations after 3
hours’ activation, and stained cells using antibodies specific for phosphorylated
ERK1/2. Analysis of activated CD4+ SP activated (CD25+) cells showed no in-
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Figure 3.12: Effect of computationally adding or removing Dicerlox/lox thymo-
cytes to a population of lckCre Dicer∆/∆ thymocytes - (a) Change in CV pro-
duced by computational addition of a population of Dicerlox/lox cells to a lck-
Cre Dicer∆/∆ population. Using CD69 expression data from lckCre Dicer∆/∆ and
Dicerlox/lox CD4+ SP thymocytes activated as in 3.9, the graph shows how the to-
tal population CV varies as a percentage of Dicerlox/lox cells in the population is
increased. (b) Change in CV produced by computational subtraction of a popula-
tion of Dicerlox/lox cells from a lckCre Dicer∆/∆ population. Using CD69 expres-
sion data from lckCre lckCre Dicer∆/∆ and Dicerlox/lox CD4+ SP thymocytes acti-
vated as in 3.9, the graph shows how the total population CV varies as a percentage
of Dicerlox/lox cells subtracted from the population is increased. Error bars in both
graphs show standard error from simulations using 10 different sets of results.
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crease in either mean ppERK levels or the CV of ppERK (Figure 3.13a and b).
DP cells could not be quantified by this method, as they show insufficient CD25
expression after three hours activation for reliable analysis of the activated cell
population. To investigate ERK phosphorylation in activated DP cells, we also
sorted populations of DP and CD4+ SP Dicerlox/lox and lckCre Dicer∆/∆ cells
and activated for 3 hours with plate-bound anti-TCR and anti-CD28 antibodies.
These cells were lysed and were assayed for ppERK by western blotting. As with
the flow cytometry data, no increase of ERK phosphorylation was seen (Figure
3.13c and d), suggesting that Dicer-dependent changes in components of the ERK
pathway are not responsible for the observed changes in CD69 expression..
In conclusion, we have identified a number of genes which show increased
cell-cell variation, as measured by the CV, in Dicer-deleted T-cells. In particular,
the cell surface markers CD44 and Sca-1 show increased expression in miRNA-
depleted thymocytes, consistent with their regulation by miRNAs. They also
show increased cell-cell variation, suggesting that miRNAs may play a role in
regulating the variation in levels of specific genes during development. We also
looked at regulation of CD69 during T-cell activation, and found that follow-
ing activation, Dicer-dependent increases in mean CD69 expression are recorded
at all stages of development. In thymocytes, this increase in mean expression
is also accompanied by an increase in cell-cell variation in Dicer-deleted cells.
However, this increase in variation is not seen in peripheral T-cells, suggest-
ing that the mechanism is developmentally regulated. Further investigation has
shown that these changes in gene expression and noise are not due to residual
miRNA expression in Dicer-deleted cells, or by increased cell death of Dicer-
deleted cells during activation. Investigation of changes in the upstream ERK
pathway showed no increase in ERK phosphorylation which could explain the
increase in CD69 expression and noise.
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Figure 3.13: Effect of Dicer Deletion on ppERK signalling - (a) Typical flow cy-
tometry plot of ERK phosphorylation in activated Dicerlox/lox (black) and lckCre
Dicer∆/∆ (red)CD25+ CD4+ SP thymocytes and unactivated Dicerlox/lox CD4+ SP
thymocytes (dashed line). (b-c) Relative change in (b) mean level or (c) CV of ERK
phosphorylation measured by flow cytometry in Dicerlox/lox (black) and lckCre
Dicer∆/∆ (red) CD4+ SP thymocytes after 3 hours activation with anti-TCR and anti-
cd28 antibodies. Box-and-whiskers plot summarises results from 8 replicates. (d)
Western blot for ppERK and lamin B in activated and unactivated WT and Dicer-
deleted thymocytes. (e) Quantified ppERK levels, normalised to lamin B. Error bars
show standard error from four separate experiments.
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4MicroRNA regulation of gene
expression noise
4.1 Dicer-dependent regulation ofCd69,Cd44 and Sca-
1 3’ UTRs
Identifying genes which show increased variation and gene expression on dele-
tion of Dicer is not sufficient to show that they are miRNA targets: while it is
possible that the changes in gene expression observed are due to depletion of a
specific miRNA targeting that gene, they could also be due to other effects ofDicer
deletion, such as regulation of the gene under investigation by another miRNA
target.
To determine whether the genes identified were direct targets of microRNAs,
and that the changes in expression and variation we observed were not a down-
stream effect from changes in the expression of another gene regulated by miRNAs,
we investigated whether each gene was a direct miRNA target. We used the Tar-
getScan algorithm64 to obtain computational predictions of which miRNAs were
likely to target Cd69, Cd44 and Sca-1 transcripts, based on complementarity to
miRNA seed sequences and evolutionary conservation. The 842 nt Cd69 3’ UTR
was found to contain three potential miRNA binding sites, for the miRNA fam-
ilies miR-181, miR-130 and miR-17-20, with binding sites for the seed sequences
starting at positions 255, 354 and 391 respectively. The 2990 nt Cd44 3’ UTR con-
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tains a single predicted binding site for the miR-21 family, starting at position 573
within the 3’ UTR. There were no conserved predicted miRNA binding sites in
the 385 nt Sca-1 3’ UTR (Figure 4.1a). All three 3’ UTRs contained many poorly
conserved miRNA binding sites: these are less likely to be functional sites, as
evolutionary conservation is a predictor of functional miRNA binding sites60.
To test whether these mRNAs were targeted by miRNAs, we developed a
dual fluorescence (DF) retroviral reporter construct containing two fluorescent
reporter proteins, eGFP and mCherry, under the control of the separate LTR and
PGK promoters, as well as a cloning site in the 3’ UTR of the eGFP transcript.
In a similar manner to luciferase reporter constructs, 3’ UTRs of interest can be
cloned into this site, and the effect of the 3’ UTR on expression of GFP relative to
mCherry can be recorded. This approach has several advantages over traditional
approaches based on luciferase vectors, including the ability to directly measure
reporter expression by flow cytometry, making it easier to directly measure the
effect of endogenous miRNAs on construct expression in sorted primary cell pop-
ulations.
We cloned the 3’ UTRs of Cd69 and Sca-1 (excluding the polyA signal from
each 3’ UTR) and bases 1-891 (containing the predicted miR-21 binding site, as the
entire 3’ UTR of Cd44 was too long to clone into a single construct) of the Cd44 3’
UTR into the fluorescent reporter construct (Figure 4.2a). For successful retroviral
infection, a population of dividing cells is required. To achieve this in peripheral
cells, cells were activated with CD3/CD28-coated beads for 24 hours to drive cell
division, and infected with retrovirus containing the reporter construct. After a
further 24 hours, expression of eGFP and mCherry could be directly quantified
by flow cytometry, with an infected mCherry+ eGFP+ population of ∼ 30-40% of
T-cells(Figure 4.2a).
This allowed miRNA-dependent regulation to be measured by comparing the
relative expression of eGFP in WT and miRNA-depleted cells. To model the rela-
tionship between GFP and mCherry, orthogonal linear regression, a variation of
linear regression that assumes errors in both variables, was used, with the relative
level of eGFP to mCherry calculated as the gradient of the fitted line. These ratios
of eGFP expression to cherry expression are normalised to the eGFP/mCherry
ratio of the empty vector, to quantify the change in eGFP expression in experi-
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Figure 4.1: Dual fluorescence reporter construct - (a) Schematic of dual fluorescence
reporter construct and inserted 3’ UTRs, showing Targetscan-predicted miRNA bind-
ing sites (b) Typical density plot showing mCherry and eGFP expression of the empty
vector in CD4+ peripheral T-cells, and representative gating for mCherry+ eGFP+
cells. Percentages indicate proportion of cells in each quadrant. (c) Representative
log-log dot plot of gated mCherry+ eGFP+ T-cells expressing the construct contain-
ing the Cd69 3’ UTR in Dicerlox/lox and lckCre Dicer∆/∆ cells, showing fitted lines
used to calculate increase in eGFP expression.
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Figure 4.2: Dual fluorescence reporter construct shows Dicer-dependent downreg-
ulation of Cd69 expression in peripheral T-cells - (a) Changes in eGFP expression
relative to empty DF vector in Dicerlox/lox (black) and lckCre Dicer∆/∆ (red) CD4+
peripheral T-cells (b) Changes in GFP relative to empty DF vector in Dicerlox/lox
(black) and lckCre Dicer∆/∆ (red) CD8+ peripheral T-cells. All cells activated with
CD3/CD28 beads for 24 hours to allow efficient infection. Error bars in both graphs
indicate standard error from four experiments.
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mental vectors compared to the empty vector. By comparing eGFP expression
from Dicerlox/lox and Dicer∆/∆ cells the level of miRNA-dependent repression
can also be observed.
In peripheral cells, only the Cd69 3’ UTR showed miRNA dependent regu-
lation: peripheral CD4+ Dicerlox/lox cells infected with the DF vector contain-
ing the Cd69 3’ UTR showed a ∼40% decrease in eGFP expression relative to the
empty vector; in CD4Cre Dicer∆/∆ cells a∼7.5-fold increase in GFP expression is
seen instead, indicating that as well as repressive miRNA-binding sites, the Cd69
3’ UTR may contain sequences that enhance expression. Neither the Sca-1 3’ UTR
nor the Cd44 3’ UTR fragment showed significant Dicer-dependent increases in
eGFP expression, and insertion of the Cd44 3’ UTR section actually showed con-
siderable upregulation of eGFP expression in both WT and Dicer-deleted cells,
suggesting that the Cd44 section contains sequences which enhance gene expres-
sion in a miRNA-independent manner (Figure 4.2a). Similar results were seen
in CD8+ T-cells: although insertion of the Cd69 3’ UTR produced no downregu-
lation in eGFP expression relative to the empty DF vector, deletion of Dicer pro-
duces a ∼9-fold increase in eGFP expression, consistent with miRNA-mediated
repression of eGFP by the Cd69 3’ UTR. Again, neither the Sca-1 3’ UTR nor the
Cd44 3’ UTR fragment shows significant Dicer-dependent upregulation (Figure
4.2b).
This experiment was repeated in thymocytes; to successfully infect the re-
porters into thymocytes, they need to be cultured for several days as part of a fetal
thymic organ culture (FTOC) system, in which fetal thymic lobes are incubated in
media supplemented with deoxyguanosine to eliminate native thymocytes. The
remaining stromal cells are mixed with thymocytes infected with the DF vector
(Figure 4.3a). The stromal cells provide support for immature DN thymocytes to
divide, become infected with the vector and mature into DP and SP thymocytes.
Because Dicer∆/∆ thymocytes show increased cell mortality, they could not be
cultured this way, so all results in thymocytes are from wild-type C57Bl/6 mice.
As with CD4+ peripheral T-cells, only the Cd69 3’ UTR produced any downreg-
ulation in GFP expression: this was observed in DP, and both CD4+ and CD8+
SP cells, producing reductions of 75%, 55% and 72% in GFP expression in DP,
CD4+ SP and CD8+ cells relative to the empty vector. Expression of constructs
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Figure 4.3: Expression of reporter constructs using fetal thymic organ cultures -
(a) Schematic of thymic organ culture system. (b) Typical flow cytometry plot from
DP thymocytes infected with empty reporter vector in fetal thymic organ culture.
Percentages show relative frequency of each quadrant.
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Figure 4.4: Cd69 3’ UTR represses reporter construct expression in thymocytes -
Expression of DF reporter construct containing Cd69, Sca-1 and Cd44 3’ UTRs in (a)
Double positive (b) CD4+ Single positive and (c) CD8+ SP thymocytes. Plots show
GFP expression relative to empty DF vector. Error bars indicate standard error from
between 4 and 7 experiments.
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containing the SCA1 and CD44 3’ UTRs showed an increase in eGFP expression,
indicating that they may contain sequences which enhance expression (Figure
4.4). As miRNA-deficient cells cannot be infected using FTOC due to high cell
death, miRNA-dependent repression cannot be directly observed in thymocytes.
Because their 3’ UTRs do not produce any repression of eGFP expression in WT
cells, it is unclear whether Cd44 and Sca-1 are direct targets of miRNAs in thymo-
cytes, but given their lack of Dicer-dependent regulation in peripheral T-cells, we
focused on further investigating the regulation of the Cd69 3’ UTR by miRNAs.
4.2 Cd69 is regulated by multiple microRNAs
In order to identify repressive elements in the Cd69 3’ UTR we cloned a number
of truncations of the 842 bp Cd69 3’ UTR into the DF vector and expressed them
in thymocytes. In both DP and CD4+ SP thymocytes, segments of the Cd69 3’
UTR which contained bases 200-430 showed roughly equal levels of repression.
However, the 3’ UTR truncation containing only bases 410-842 showed ∼12-fold
upregulation of eGFP expression (Figure 4.5). This suggests that bases 200-430 of
the 3’ UTR (which contain all three predicted miRNA binding sites) contain the
principal repressive sequences in the 3’ UTR.
To further dissect the regulation of Cd69 by miRNAs, we mutated each of the
predicted binding sites in theCd69 3’ UTR, randomising the seed sequence at each
predicted binding site, and observed the effect this had on reporter expression in
T-cells at all three stages of development. If the site is in fact a miRNA binding
site, this should result in increased eGFP expression relative to the complete 3’
UTR. In peripheral T-cells, mutating each of the predicted miRNA binding sites
showed the Dicer-dependent effect of each predicted site on eGFP expression.
Mutating the predicted miR-181 family binding site in the Cd69 3’ UTR produced
no change in eGFP expression compared to the unmutated Cd69 3’ UTR vector,
but mutating the miR-130 and miR-20 family binding sites resulted in upregula-
tion of∼2- and∼5-fold, respectively, relative to the complete Cd69 3’ UTR (Figure
4.6a). These actually increased eGFP expression over the basal level of expression
from the empty DF vector, suggesting that as well as repressive miRNA binding
sites, there are elements of the Cd69 3’ UTR which can enhance expression of
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Figure 4.5: Repressive regions of the Cd69 3’ UTR fall in the 0-410 region -
(a)Schematic of truncations made to the Cd69 3’ UTR, showing location of predicted
miRNA binding sites. (b-c)Effect of truncation of Cd69 3’ UTR: eGFP expression (rel-
ative to the empty DF vector) from (b) DP and (c) CD4+ SP thymocytes infected with
DF reporter construct containing full-length Cd69 3’ UTR (bases 0-842) and truncated
versions (bases 0-430, 0-630, 200-842 and 410-842) Error bars show standard error
from two experiments.
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eGFP. Deletion of Dicer resulted in a ∼10-fold upregulation of eGFP expression
in all Cd69 3’ UTR-containing constructs, abolishing any difference in expression
due to miRNA binding site mutations. Similar results were seen in CD8+ periph-
eral T-cells: mutation of the miR-130 and miR-20 binding sites produces Dicer-
dependent increases in eGFP expression of ∼2- and ∼7-fold respectively (Figure
4.6b). These patterns of expression are consistent with the miR-130 and miR-20
families regulating Cd69 expression in both types of peripheral T-cells. It does not
appear that the miR-181 family site has a repressive effect in peripheral T-cells.
In thymocytes, mutation of any of the three sites produces similar results in all
three cell types investigated. In DP thymocytes, mutation of the miR-181, miR-
130 and miR-20 binding sites results in a decrease of repression from the Cd69
3’ UTR by 35%, 45% and 80% respectively, consistent with targeting of the 3’
UTR by endogenous members of each family of miRNAs in thymocytes. These
effects are also additive: multiple mutations of the different binding sites result
in increased expression of eGFP: mutation of all three predicted sites results in a
∼ 7-fold increase in eGFP expression. Similar results are also observed in both
CD4+ and CD8+ SP thymocytes (Figure 4.7b and c). These results show that the
Cd69 3’ UTR is regulated by all three predicted miRNA binding sites in immature
thymocytes.
4.3 Changes in miRNA expression in response to T-
cell activation
If miRNAs form part of genetic regulatory networks which reduce noise, we need
to identify the mechanisms by which they are co-regulated with other genes,
and whether they function as part of motifs such FFLs or negative feedback
loops. One possibility for the regulation of CD69 is that miRNAs are also upreg-
ulated during activation. For example, computational prediction with the miR-
gen database of predicted miRNA-regulating transcription factors217 suggested
that the transcription factor AP-1, a target of the ERK signalling pathway, might
target promoters of both miR-181a and Cd69. To test whether miR-181 or other
miRNAs might be upregulated by T-cell activation we sorted populations of DP,
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Figure 4.6: Mutation of predicted miR-130 and miR-20 family binding sites re-
duces Dicer-dependent repression of the Cd69 3’ UTR in mature T-cells - (a-b)
Changes in GFP expression in Dicerlox/lox (black) and lckCre Dicer∆/∆ (red) (a)
CD4+ and (b) CD8+ peripheral cells activated and infected with DF constructs con-
taining the Cd69 3’ UTR with the indicated mutations made to predicted miRNA
binding sites. All expression values shown relative to empty DF vector and scaled to
unmutated Cd69 3’ UTR. Error bars show standard error calculated from between 4
and 14 different experiments, depending on mutation.
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Figure 4.7: Mutation of predicted miR-181, miR-130 and miR-20 family binding
sites reduces repression of the Cd69 3’ UTR in thymocytes - Fold-change in GFP
expression in (a) DP thymocytes (b) CD4+ SP thymocytes (c) CD8+ SP thymocytes
relative to empty DF vector of DF vector containing the Cd69 3’ UTR, with indicated
miRNA family binding sites mutated. All expression values shown relative to empty
DF vector and scaled to unmutated Cd69 3’ UTR. Error bars show standard error
calculated from between 4 and 14 different experiments, depending on mutation.
98
4.3 Changes in miRNA expression in response to T-cell activation
CD4+ SP thymocytes and CD4+ peripheral cells from WT C57Bl/6 mice for ac-
tivated (CD25+ CD69+) cells after 18 hours’ activation with anti-TCR antibody
(500 ng/ml, costimulated with 2 µg/ml anti-CD28 antibody) and profiled Cd69-
targeting miRNA families for changes in expression by RT-qPCR (Figure 4.8).
These data show two main results in thymocytes: a downregulation in expres-
sion of miR-181 family members, and an upregulation in members of the miR-20
family, particularly miR-17 and miR-20a. In peripheral T-cells, upregulation of
the miR-20 family, particularly miR-17, remains, but the level of miR-181 fam-
ily expression in unactivated peripheral T-cells is reduced compared with thy-
mocytes, and little downregulation is observed. The levels of the miR-130/301
family remain low in both activated and unactivated cells.
However, analysis of Cd69 mRNA levels after T-cell activation shows that
Cd69 levels rise rapidly after activation, peaking after 3-6 hours, and then decline
to original levels170. If Cd69 is regulated by a miRNA which has the same pat-
terns of expression, this suggests that miRNA levels could rise along with CD69,
and similarly decline, so that co-regulation of Cd69 and a targeting miRNA might
occur, but not be detectable 18 hours after activation. To address this possibil-
ity, I also activated CD4+ SP thymocytes and mature CD4+ T-cells for 3 hours,
and investigated changes in miRNA levels. After 3 hours’ activation, markers
of activation such as CD69 and CD25 are not yet sufficiently expressed to allow
sorting of a population into activated and unactivated cells by their expression.
Instead, to profile miRNA expression in cells after 3 hours’ activation, thymocytes
and peripheral T-cells were sorted for CD4+ single positive cells, of which ∼70%
will become activated upon stimulation. These sorted CD4+ cells were then acti-
vated with anti-TCR antibody for three hours, and this population of cells, which
mainly consists of activated cells, were lysed and profiled for miRNA expression
with RT-qPCR (Figure 4.9). After 3 hours’ activation, we found little change in
the levels of any miRNA profiled, suggesting that the upregulation of Cd69 ex-
pression after activation is not mirrored in any of the miRNAs predicted to target
the Cd69 3’ UTR.
T-cell activation in thymocytes also requires a significant alteration in cell mor-
phology, including a significant increase in cell size. Changes in cell volume could
also affect expression of housekeeping genes such as snoRNAs used to normalise
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Figure 4.8: Changes in miRNA levels after 18 hours’ activation - (a) WT Thymocytes
and (b) peripheral T-cells activated for 18 hours with 500 ng/ml anti-TCR antibody,
then sorted by flow cytometry into DP, CD4+ SP and CD4+ populations. MicroRNA
levels in activated cells and unactivated controls then measured by RT-qPCR. Expres-
sion levels normalised to snoRNAs 135 and 202. Error bars show standard error from
three experiments.
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miRNA quantification by RT-qPCR. To check that this was not masking changes
in miRNA expression, we established copy-number calibration curves for miR-
181a and miR-20a to investigate whether changes in copy number between acti-
vated and unactivated cells was significantly different. As with earlier profiling,
CD4+ SP thymocytes from WT C57Bl/6 mice were sorted and activated for 3
hours with anti-TCR and anti-CD28 antibodies. Activated and unactivated con-
trol cells were assayed for expression of miR-181a and miR-20a, along with a cali-
bration curve to allow direct calculation of copy number for both miRNAs. Copy
numbers showed no significant change in miRNA numbers after activation, sup-
porting our original findings that miRNA levels do not change significantly after
3 hours of T-cell activation.
4.4 miR-181a expression is developmentally regulated
Next we considered whether changes in miRNA expression might be triggered
by developmental changes, rather than activation. Previous work has shown that
miR-181a is developmentally regulated, with reduced expression as thymocytes
mature193. We theorised that miR-181a might be continuously reduced in ex-
pression as cells mature,and that this might work to reduce cell-cell variation by
counteracting other developmental changes, such as changes in the sensitivity of
the TCR to stimuli, producing more consistent expression of CD69 across a popu-
lation of cells of differing maturity. We subdivided DP and CD4+ SP populations
by maturity by sorting for expression of TCRα, which is expressed as DP cells
mature, and for CD24, which is downregulated as CD4+ SP cells mature. Copy
numbers of miR-181 in each population were determined by RT-qPCR. By doing
this, we can see a continuous reduction of miR-181a expression as T-cells mature
(Figure 4.10).
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Figure 4.9: Changes in miRNA levels after 3 hours’ activation - (a) Thymocytes and
(b) peripheral T-cells sorted into CD4+ populations and activated (with 500 ng/ml
anti-TCR and 2 µg/ml anti-CD28 antibodies) for 3 hours. MicroRNA levels in acti-
vated cells and unactivated controls then measured by RT-qPCR. Expression levels
normalised to snoRNAs 135 and 202. (c) Copy numbers of miR-181a and miR-20a in
T-cells activated for 3 hours. Error bars show standard error from three experiments.
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Figure 4.10: Changes in miR-181a expression over thymocyte development - Thy-
mocytes sorted into developmental substages and miR-181a copy number per cell
assayed by RT-qPCR. Error bars indicate standard error from three separate experi-
ments.
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4.5 Effect of inhibition of specific miRNAs on CD69
expression
To verify that each of the miRNAs identified as regulators of CD69 had a role in
regulating the changes in CD69 expression we had observed, we tried to knock
down expression of specfic miRNAs (miR-181a, miR20a and miR-130b) by trans-
fection of hairpin miRNA inhibitors into fetal thymocytes in an FTOC system.
After 24 hours, cultures were resuspended and thymocytes were activated for 18
hours with anti-TCR and anti-CD28 antibodies. These activated cells were anal-
ysed for CD69 expression and cell surface markers by flow cytometry. Inhibition
of both miR-181a and miR-20a miRNAs produced an increase in CD69 expression
in activated DP thymocytes, of 12% and 7% respectively (Figure 4.11a). Similar
results were observed in CD4+ SP thymocytes, but the effect of miR-181a inhi-
bition was smaller (∼ 7%) and the effect of inhibition of miR-20a was slightly
larger (∼ 10%) (Figure 4.11b). No significant effect was seen from attempts to
knockdown miR-130b in either cell type. We also looked at the effect of individ-
ual miRNA inhibition on the CV of CD69 expression in activated cells: in both DP
and CD4+ SP thymocytes, no increase in CV was observed after inhibition of any
of the individual miRNAs tested (Figure 4.11c and d). The relatively small effect
of knockdown of miR-20a, which is predicted to be the strongest repressor of the
Cd69 3’ UTR from mutating the predicted miRNA binding sites in the reporter
constructs, may be due to redundancy effects in miRNA families, as miR-20a has
many co-expressed family members.
To reconcile these results with our reporter constructs, we also repeated these
experiments using tiny locked nucleic acid (LNA) inhibitors, short 8-nt sequences
of LNA, a modified polynucleotide which shows superior stability and binding
compared to RNA, and, as they only target the seed sequence of a miRNA family,
are capable of targeting an entire family of miRNAs212. As with the hairpin in-
hibitors, thymocytes were transfected with LNAs using a fetal thymic organ cul-
ture system, incubated for 24 hours to allow knockdown of miRNAs, and then
activated for 18 hours with 500 ng/ml anti-TCR antibody and anti-CD28 anti-
body.
Inhibition of the miR-181 and miR-130 families showed no increase in CD69
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Figure 4.11: Effect of transfection of miRNA hairpin inhibitors into thymocytes -
(a-b) Change in mean CD69 expression in activated (a) DP and (b) CD4+ SP thymo-
cytes on transfection of hairpin inhibitors to miR-181a, miR-130b or miR-20a, relative
to control hairpin. (c-d) Change in CV of CD69 expression in (c) DP and (d) CD4+
SP thymocytes on transfection of hairpin inhibitors to miR-181a, miR-130b or miR-
20a, relative to control hairpin. Error bars indicate standard error calculated from
three biological replicates. * indicates p ≤ 0.05. ** indicates p ≤ 0.01. P-statistics
determined by two-tailed Student’s T-test.
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Figure 4.12: Effect of transfection of tiny LNA miRNA inhibitors into thymocytes
- (a-b) Change in mean CD69 expression in activated (a) DP and (b) CD4+ SP thymo-
cytes on transfection of LNA inhibitors to miR-181a, miR-130b or miR-20a, relative
to control LNA. (c-d) Change in CV of CD69 expression in (c) DP and (d) CD4+ SP
thymocytes on transfection of hairpin inhibitors to miR-181a, miR-130b or miR-20a,
relative to control LNA. Error bars indicate standard error calculated from three bio-
logical replicates.
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expression, while inhibition of the miR-20 family showed an upregulation of ∼
35% in activated DP thymocytes, and ∼ 30% in CD4+ thymocytes. Similar in-
creases in expression were observed when all three LNAs were co-transfected
into thymocytes together. The upregulation of mean CD69 expression when the
miR-20 family is inhibited is consistent with the broader specificity of LNAs al-
lowing targeting of the whole family. Analysis of changes in CD69 CV showed
no upregulation in CV following inhibition by any of the LNAs (Figure 4.12c and
d).
4.6 Deletion of miR-181ab cluster increases CD69 ex-
pression on activation
Given apparently contradictory results on the effect of inhibiting the miR-181
family in thymocytes, to further investigate the role of the miR-181 family in
regulating CD69, we obtained mice from the Chen lab which contained a muta-
tion in the miR-181ab-1 loci, which expresses the majority of the miR-181 family
members. Thymocytes and peripheral T-cells from wild-type C57Bl/6 mice, miR-
181ab-1 -/- homozygous and miR-181ab-1 -/+ heterozygous mice were activated
for 18 hours with anti-TCR (500 ng/ml) and anti-CD28 (2 µg/ml) antibodies, and
the expression of CD69 in activated cells was analysed by flow cytometry.
In activated T-cells at all stages of development, a clear increase in CD69 ex-
pression of ∼20% was seen in miR-181a/b-deleted cells compared to wild-type,
consistent with direct miR-181 regulation of CD69 expression. However, no in-
crease in CD69 CV was seen in miR-181a/b-depleted cells (Figure 4.13.
4.7 In silico experiments show possible models of noise
regulation
To look further at how miRNAs might regulate biological noise as part of regu-
latory motifs, we carried out a number of simulations of simple FFLs, using the
Gillespie exact stochastic simulation method8, building on models described in
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Figure 4.13: Knockout of miR-181ab expression increases CD69 expression - ((a-
c) Mean or (d-f) CV of CD69 expression in activated CD25+ CD69+ T-cells at from
miR-181ab-1 -/-, miR-181ab-1 -/+ and WT mice at indicated levels of development.
CD69 expression measured by flow cytometry after 18 hours’ activation with 500
ng/ml anti-TCR antibody and 2 µg/ml anti-cd28. Data for each condition from at
least 5 mice.
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recent theoretical studies (See Introduction)138. For regulation by transcription
factors, TF regulation is modelled as a Hill function, in which the rate constant of
transcription responds sigmoidally to increasing concentrations of transcription
factor:
k =
kb[TF]c
hc + [TF]c
Where k is the rate constant, kb is the base rate of transcription, [TF] is the
concentration of transcription factor, h is the dissociation coefficient, which de-
termines the strength of the response to the TF and c is the Hill coefficient, which
determines how sharp the response to increasing concentration of TF is.
As miRNAs may act through multiple mechanisms, we modelled two differ-
ent mechanisms of miRNA action, to determine how different mechanisms might
affect the control of noise. First, we modelled miRNAs as purely repressive of
translation, modelling their action as a reduction in the translation rate of mR-
NAs, dependent on the concentration of miRNAs according to a Hill equation:
k =
kb
1+ ( [miRNA]h )
c
Where k is the resulting rate constant, kb is the base rate of translation, [miRNA]
is the miRNA concentration, h is the dissociation constant, and c is the Hill co-
efficient. Rates of other reactions, such as mRNA or protein degradation, were
modelled as proportional to the concentration of their limiting factor multiplied
by a rate constant (for full system specifications, see Appendix 1). Using values
for the rate constants derived from previous models138, we simulated this sys-
tem, and a miRNA-free system in which a transcription factor regulates only an
output protein, to obtain steady-state values for simulated protein expression. By
comparing a system with miRNA regulation to the same system without, we can
see that a miRNA-containing FFL is clearly capable of reducing noise compared
to a circuit with no miRNA regulation (Figure 4.14c). Comparing circuits with
and without miRNA regulation showed a relative increase in mean output pro-
tein expression of 50% and a increase in relative CV of 42% , similar to the changes
seen in our experimental systems.
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Figure 4.14: In silico experiments show miRNAs can regulate noise in theoretical
models of regulatory motifs - (a) Schematic of miRNA FFL model in which miRNAs
inhibit translation (b) Schematic of miRNA FFL model in which miRNAs bind to
mRNAs and enhance degradation of the mRNA (c) Density plot of 10,000 simulations
of gene regulation with (black) and without (red) miRNA regulation. Parameters
are: rate of TF transcription 0.06, rate of TF and output mRNA degradation 0.006,
rate of TF translation 0.04, rate of TF and output protein degradation 0.002, base rate
of miRNA transcription 0.5, dissociation constant for TF regulation of miRNA and
output mRNA transcription 200, rate of miRNA degradation 0.006, rate of output
mRNA transcription 0.8, base rate of output translation 0.04, miRNA dissociation
constant 60, and all Hill coefficients, 2. (d) Density plot of 10,000 simulations of gene
regulation with (black) and without (red) miRNA regulation. Rate constants are the
same as in the first model, but with no translational repression: the rate of output
protein translation is 0.04, and with a number of additional rate constants: the rate
constant of miRNA-mRNA complex formation and dissociation is 0.0001, while the
rate constant for mRNA degradation in complex is 0.02.
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Secondly, we developed a stochastic model based on deterministic models re-
cently developed to look at thresholding in miRNA repression, in which miRNAs
bind to mRNAs to form a miRNA-mRNA complex, from which mRNAs can-
not be translated and which can either degrade or release the mRNA (Figure
4.14b)218. Simulating this system produced a similar, though more modest reg-
ulation of noise: comparing the circuit with miRNA regulation to the circuit
without showed an increase in mean output expression of 70% and an increase
in CV of 23% (Figure 4.14d). The smaller noise regulation may be due to the
additional variability introduced by modelling the additional steps of random
miRNA-mRNA binding.
Varying the parameters associated with production and binding of the tran-
scription factor produced a number of different responses, depending on which
constants were altered. These responses could be divided into a number of dif-
ferent categories.
Changing rate constants associated with the production and action of the tran-
scription factor, such as the rate of transcription or translation, showed that noise
reduction occurs only at intermediate values of the rate constants: if too little
transcription factor is produced, no downstream transcription occurs, conversely,
if sufficient TF is produced to saturate the system and produce maximum tran-
scription and noise from the transcription factor is not transmitted to the output
protein, and miRNA regulation has little effect on noise (Figure 4.15a and b).
Altering the rate of miRNA decay in both systems also showed that maxi-
mal regulation of variation was achieved at intermediate levels of repression: if
miRNA decay is slow then levels of miRNA are high, resulting in strong repres-
sion of target mRNAs, but there is no control of noise, while if miRNA decay
is fast miRNAs decay too fast to have significant effect, and no repression oc-
curs. Optimal repression of noise occurs with a repression of between 20-60% of
unregulated protein levels (Figure 4.15c). Similar results are obtained by vary-
ing the miRNA dissociation constant in the model of translational repression by
miRNAs.
Changing rate constants that affect the base level of the output protein, such
as the base rate of output transcription, or the base rate of output translation in
the translational inhibition model, has little effect on the relative levels of protein
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Figure 4.15: Changing rate constants in models shows noise regulation strongest
at intermediate levels of repression by miRNAs - (a-d) The effect of changing rates
constants in both miRNA models. All other constants are unchanged from previous
figure, while plots show the relative effect on mean and CV of output expression by
changing (a) the rate of transcription factor translation, (b) the rate of transcription
factor degradation, (c) the miRNA degradation rate and (d) the base rate of output
protein transcription. Blue line indicates the miRNA-mRNA binding model, while
the red line indicates the results in the translational inhibition model. (e-f) Effect of
changing parameters of the miRNA-mRNA binding model. Effect of changing (e)
the rate of miRNA binding to mRNA and (f) the rate of mRNA degradation from the
miRNA-mRNA complex. 200 simulations run per condition.
112
4.7 In silico experiments show possible models of noise regulation
expression, but produces an initial increase in relative CVs, before reaching a
stable maximum level of noise regulation(Figure 4.15d).
Modifying the rates of miRNA-mRNA binding and miRNA-mediated mRNA
degradation in the mRNA degradation model produces some interesting results:
increasing the miRNA binding rate results in a linear increase in repression of
protein output, and, as seen before, produces maximal noise repression at inter-
mediate levels of repression (Figure 4.15e). Conversely, altering the rate of degra-
dation of mRNA from the miRNA-mRNA complex results in no change in mean
repression, but alters the strength of the regulation of noise observed(Figure 4.15f).
This is particularly interesting as it represents a potential mechanism by which
the noise might be regulated independently from the mean level of expression,
although this mechanism is dependent on miRNA-mRNA binding being an ac-
curate model of miRNA action.
Despite these changes, it seems that the miRNA-dependent regulation of noise
is remarkably robust: under conditions of moderate repression (such as repres-
sion of 20-50% of gene expression by the miRNA), FFLs seem to be effective at re-
ducing noise in downstream genes under a wide variety of different parameters.
This reduction is typically fairly modest, typically around 20-30%. These effects
also seem to be robust to changes in potential mechanisms of miRNA action: de-
spite very different models of miRNA effects, both models show a reduction in
noise under most conditions.
In conclusion, we have investigated the direct regulation of Cd44, Sca-1 and
Cd69 by miRNAs in thymocytes, and have found miRNA-dependent inhibition
of the Cd69 3’ UTR during T-cell development. In particular, we have found pre-
dicted binding sites for three families of miRNAs, miR-181, miR-130 and miR-20,
which alleviate repression when mutated. We profiled changes in miRNA expres-
sion on activation in T-cells to determine whether miRNAs that targeted Cd69
were also upregulated on activation, and observed that members of the miR-181
family, which are highly expressed in thymocytes but not in peripheral T-cells, are
downregulated on activation and members of the miR-20 family are upregulated
in activation in both thymocytes and peripheral T-cells. Members of the miR-130
family are expressed at low levels in both activated and unactivated cells. To de-
termine whether developmental regulation of miR-181 might change as T-cells
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mature, we profiled miR-181a expression across subsets of thymocytes of differ-
ent maturities, to confirm that miR-181 expression shows a decline as cells ma-
ture. We verified the miRNA regulation of CD69 with a combination of specific
miRNA deletions and miRNA inhibition experiments, which verified that knock-
down of miR-181 and miR-20 resulted in an increase in the expression of CD69 in
activated thymocytes. However, no increase in cell variation was observed from
the knockdown of any single miRNA. To investigate theoretical mechanisms by
which miRNAs might reduce variation, we used computational models to show
that simple models of the FFL, using biologically plausible parameters, can pro-
duce similar changes in variation to those seen in our experimental systems. By
varying the model parameters, we have also seen that miRNA regulation in these
models produce a reduction in variation under a wide variety of parameters.
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5.1 Overview
MicroRNAs are small non-coding RNAs which post-transcriptionally repress tar-
get mRNAs and have previously been shown to have a number of important roles
in many aspects of animal development. In particular, it has been suggested that
one of the functions of miRNAs is to enhance the robustness of gene regulatory
networks to perturbations, including biological noise. Computational simula-
tions have shown that miRNAs may function to reduce noise as part of network
motifs such as feedforward loops138, and some studies have shown that deletion
of miRNAs results in reduced robustness to environmental fluctuations during
development141, but no study has yet shown a direct link between miRNAs and
regulation of biological noise. Previous work in our lab has shown that miRNAs,
particularly members of the miR-181 and miR-20 families, target many genes
which are differentially expressed during T-cell development215. To investigate
the role of miRNAs in the regulation of biological noise during development, we
identified a number of genes which showed increased cell-cell variation in Dicer-
deleted thymocytes. To confirm that these genes were direct miRNA targets, we
identified miRNA binding sites in these genes using a fluorescent reporter con-
struct, and validated them using miRNA knockdown experiments, looking in
particular at the marker of activation CD69. Finally, we investigated how CD69
and the miRNAs which target it might fit into gene regulatory networks which
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would act to reduce cell-cell variation.
5.2 Role of Dicer in regulating cell-cell variation
Building on previous work from the lab, which showed that a number of genes
were upregulated in Dicer-deleted thymocytes compared to wild-type thymo-
cytes215, we aimed to extend this analysis using single-cell methods to allow us
to investigate the effect of miRNAs on biological noise during development. To
assess the effect of miRNAs on biological noise, we first identified a number of
cell surface genes which showed developmental regulation, and validated this by
RT-qPCR. To observe the effect of miRNAs on the expression of these genes, we
used conditional Dicer-deleted mice to deplete miRNAs at specific stages of T-cell
development, initially looking at gene expression in DP thymocytes using flow
cytometry, which records protein expression at the single-cell level, allowing the
observation of the distribution of protein expression across a population, and the
quantification of variation as the CV.
We found that two genes, cd44 and Sca-1, showed an increase in the mean
level of protein expression in Dicer-depleted cells, consistent with regulation by
miRNAs. Quantification of cell-cell variation in protein expression by the CV of
CD44 and Sca-1 protein expression by flow cytometry in DP thymocytes showed
increased variation in Dicer-deleted cells. Sorting cells into populations express-
ing high and low levels of protein allowed us to observe how closely mRNA
expression related to protein expression observed by flow cytometry: the higher
levels of mRNA expression seen in the high protein expression groups confirm
that mRNA and protein levels are linked. These genes also showed an increase
in mRNA levels in Dicer-deleted cells, indicating that if these genes are directly
repressed by miRNAs, repression occurs through mRNA degradation, not ex-
clusively through inhibition of translation. Estimation of the measurement noise
from flow cytometry by comparing relative fluorescence of CD8α and β chains,
which are expressed at a 1:1 ratio, gave an upper bound of <20% , which compares
well with experimentally observed levels of variation, which typically show CVs
in the range of 30-100%. No difference in the estimates of experimental noise was
observed when comparing WTDicerlox/lox and Dicer-deleted lckCre Dicer∆/∆
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cells, consistent with deletion of Dicer having no effect on the experimental noise,
as opposed to the biological noise. This represents the first attempt to assess the
effect of miRNAs on cell-cell variation in mammalian cells.
We also investigated the expression of CD69, a cell surface marker that has
been previously identified as a miRNA target in T-cells. CD69 is generally ex-
pressed at low levels in thymocytes, but on activation of T-cells by engagement
of the TCR and co-receptors, it is rapidly upregulated. The expression of CD69
in the population forms a bimodal distribution, with a separable population of
activated CD69+ cells. CD69 has been previously identified as a target of the
miR-181 family, a family of miRNAs highly expressed in thymocytes193, which
suggested it as a possible candidate for forming part of an incoherent FFL, which
could act to regulate noise. In activated T-cells at the DP, CD4+ SP and CD4+ pe-
ripheral T-cell stages of development, we have seen an increase in the mean level
of CD69 expression in Dicer∆/∆ cells activated with saturating levels of anti-TCR
antibody. An increase in the CV of CD69 expression in Dicer-deleted thymocytes
is also seen. Interestingly, however, this change in CD69 noise is not observed in
peripheral T-cells, suggesting the miRNAs act to regulate noise in a developmen-
tally stage-specific manner. Whether this is due to regulation by a miRNA specific
to immature thymocytes, or because miRNAs act to control noise from a source
specific to immature thymocytes, such as the wider range of TCR specificities
expressed in thymocytes during thymic selection, remains to be seen, and repre-
sents a possible avenue for future studies. Further experiments showed that this
change in variation was not due to other effects from the deletion of Dicer, such
as residual miRNA-expressing cells, or by selective death of thymocytes during
activations. To confirm that the increase in CD69 CV was not due to changes in
the level of T-cell activation, we carried out flow cytometry and western blot-
ting for phosphorylated ERK protein, a key part of the T-cell activation signalling
pathway. These found no change in the mean level of phosphorylated ERK in
DP and CD4+ SP thymocytes, and no change in the CV of ERK phosphorylation
in CD4+ SP thymocytes. This result does not agree with a recent study which
found that inhibition of miR-181a resulted in decreased levels of ERK phospho-
rylation in activated thymocytes, which the authors attributed to changes in the
expression of protein tyrosine phosphatases such as DUSP5, DUSP6, SHP-2 and
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PTPN22194. Previous work in our lab, however, found no changes in the level
of these phosphatases in Dicer-deleted thymocytes215. It is not clear what causes
these different results, but it may be due to differing experimental protocols or to
compensatory effects from the depletion of other miRNAs in Dicer-deleted cells.
While these results do not eliminate the possibility of changes in other pathways
of T-cell activation, such as the NF-κB pathway, knockout of the RAS GTPase has
identified the ERK pathway as the principal pathway of CD69 upregulation171.
5.3 Role of miRNAs in regulatingCd69,Cd44 and Sca-
1
While the increase in cell-cell variation in Dicer-deleted thymocytes is a strong
indicator that miRNAs have a role in regulating variation, it does not exclude the
possibility that the increase in cell-cell variation is due to deregulation of other
miRNA targets, or to deregulation of other Dicer-dependent pathways. To con-
firm whether the Dicer-dependent change in cell-cell variation is due to direct
miRNA targeting of Sca-1, Cd44 or Cd69, we developed a retroviral reporter con-
struct containing two fluorescent reporter proteins, which could be used to quan-
tify the impact of inserted 3’ UTRs on reporter expression. This can be used to
determine the effect of endogenous 3’ UTR binding factors, such as miRNAs,
on reporter expression. Inserting the 3’ UTRs of Cd44, Sca-1 and Cd69 into the
reporter construct and comparing expression from these reporter constructs in
WT and Dicer-deleted peripheral T-cells showed that the Sca-1 and Cd44 3’ UTRs
show no significant Dicer-dependent repression, suggesting that these genes are
not direct miRNA targets in mature T-cells. Successful retroviral infection of thy-
mocytes requires support of developing thymocytes using FTOC. Dicer-deficient
thymocytes cannot be retrovirally infected using FTOC due to their increased
cell death, so the effect of miRNA depletion on repression cannot be directly as-
sessed in thymocytes, but insertion of the Sca-1 3’ UTR shows no repression of
eGFP expression relative to the empty vector, and insertion of the Cd44 3’ UTR
produces an increase in eGFP expression, suggesting that the effect of these 3’
UTRs is neutral or enhancing on expression. Comparison of the expression of
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reporter constructs containing the Cd69 3’ UTR in Dicer-deleted cells, however,
showed repression of eGFP expression relative to the empty vector in both pe-
ripheral T-cells and thymocytes, and Dicer-deletion in peripheral cells showed a
significant upregulation in Dicer-deleted cells. To further dissect the role of ele-
ments of the Cd69 3’UTR in miRNA-dependent repression we cloned a series of
truncations and mutations of the Cd69 3’ UTR into our reporter construct. Ex-
pression of truncated versions of the Cd69 3’ UTR in thymocytes showed broadly
similar expression in constructs containing bases 210-400 of the UTR; however,
constructs containing only the 410-842 region showed a tenfold increase in eGFP
expression, showing that the majority of repressive elements are in the 210-400
region. This corresponds to the region which contains all three predicted miRNA
binding sites. To validate the predicted binding sites, each was individually mu-
tated and the effect on eGFP expression in thymocytes and peripheral T-cells was
observed. In peripheral cells, mutation of the miR-20 and miR-130 sites resulted
in a reduction of Dicer-dependent repression, but mutation of the miR-181 site
showed no effect. In thymocytes, mutation of all three miRNA-binding sites re-
sulted in upregulation of eGFP expression consistent with miRNA-mediated re-
pression through all three binding sites. Combinatorial mutations of the binding
sites showed a roughly additive effect, with mutation of all three binding sites
resulting in an upregulation of around tenfold, which is comparable to the miR-
dependent upregulation seen when comparing the expression of eGFP from the
DF vector containing the Cd69 3’ UTR in peripheral WT and Dicer-deleted cells.
This suggests that these three sites are the major cause of the repressive effect
of the Cd69 3’ UTR in wild-type cells. The most likely reason for the observed
decline in repression mediated by the miR-181 site is the previously observed re-
duction in levels of miR-181 family members as thymocytes mature to become
peripheral T-cells60.
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5.4 MicroRNAs as part of developmental regulatory
networks
For miRNAs to have a role in regulating biological noise during development,
they must form part of the regulatory networks which control T-cell develop-
ment and activation. As well as regulating the expression of transcripts such as
Cd69, they must in turn be regulated by other transcription factors, in such a way
as to reduce the noise in the developmental system. The simplest of these pos-
sible mechanisms are basic network motifs such as negative feedback loops or
feedforward loops. To try and identify the mechanisms by which noise might be
controlled, we investigated how the miRNAs which target Cd69 might be regu-
lated themselves. Having shown that the Cd69 3’ UTR contains a number of re-
pressive miRNA binding sites, we looked at how these miRNAs were regulated
in thymocytes, in particular whether any miRNAs were upregulated following T-
cell activation, at both 3 hours and 18 hours post-activation. This found two main
effects: firstly, in thymocytes, where miR-181a and b are expressed at higher lev-
els, activation causes a downregulation in miR-181 a/b expression. This is not
seen in peripheral T-cells, as miR-181 family members are expressed at lower lev-
els. Secondly, members of the miR-20 family, particularly miR-17 and miR-20,
are upregulated following activation. Members of the miR-130/301 family were
expressed at low levels in both activated and unactivated cells. Of the potential
CD69-targeting miRNAs, only the miR-17 family shows expression that would be
consistent with co-regulation during activation, although it is expressed in both
thymocytes and mature T-cells, whereas the regulation of noise we have observed
occurs only in thymocytes.
Building on our finding that the miRNA-dependent changes in noise we have
observed are specific to immature thymocytes, and not mature T-cells, we looked
further at the miR-181 family, which has been previously documented to be highly
expressed in DP thymocytes, and then decline in expression as cells mature.
Members of the miR-181 family have been previously associated with changes
in thymocyte sensitivity to activation194, which declines significantly as thymo-
cytes mature, and it was suggested that co-regulation of the miR-181 family at
the same time as the sensitivity of the TCR changes during development might
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result in stabilisation of genes such as CD69 across a population of developing
cells. However, our finding that miR-181a/b1 deletion results in no increase in
CD69 CV on activation shows that miR-181 is not the primary miRNA involved
in the regulation of CD69 noise.
We attempted to confirm miRNA targeting of all three miRNAs in thymo-
cytes by knockdown of each miRNA. Using hairpin inhibitors to knock down
both miR-181a and miR-20a showed significant upregulation of CD69 expres-
sion in activated thymocytes. However, no change in CD69 expression was seen
when miR-130 was inhibited, and the change in CD69 expression observed from
miR-20a inhibition was smaller than would have been expected, given the up-
regulation in eGFP from the reporter constructs seen when the miR-20 family
binding site is mutated: this may be due to the high level of redundancy in the
miR-20 family. Hairpin inhibitors are specific to one particular miRNA and may
not knock down other family members, resulting in incomplete knockdown. To
address this issue further, we attempted to inhibit miRNAs with tiny-LNA in-
hibitors, a recently developed technique which uses LNAs complementary to the
seed sequence of a miRNA family to inhibit the entire family. Transfection of miR-
20 family LNAs into thymocytes produced a significantly larger increase in CD69
expression, which is consistent with the broader targeting of tiny LNAs produc-
ing stronger downregulation of the miR-20 family. However, no increase in ex-
pression was observed on transfection of tiny LNAs against either the miR-130 or
miR-181 family. In the case of miR-181, inhibition by hairpin inhibitors and LNAs
show conflicting results: this may be because of different binding affinities. It is
not clear why miR-130 shows no increase in CD69 expression when inhibited by
either hairpin or tiny-LNA inhibitors. Profiling of miRNA levels in thymocytes
showed low levels of miR-130b and miR-301a, which suggests that these miRNAs
may not be responsible for repression of CD69, despite the effect of mutating the
predicted miR-130 family binding site on expression of the reporter constructs.
It may be that the predicted miR-130 family binding site is targeted by another
miRNA, such as miR-19 which has poorly conserved binding sites located close
to or overlapping with the mutated predicted miR-130 binding site.
In all three miRNAs, inhibition with either hairpins or tiny-LNAs produced
no increase in noise. Investigation of changes in cell-cell variation requires that
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no additional noise is introduced into the system without appropriate controls to
allow the isolation of changes in noise due to changes of experimental variables.
Transfection of thymocytes with inhibitors in FTOC is an complicated procedure
which make it difficult to reproduce the conditions of adult miRNA-depleted thy-
mocytes, in particular, introducing additional variation both through the FTOC
protocols and by transfection of varying levels of inhibitor or control into indi-
vidual cells. To confirm the role of the miR-181 family in regulating CD69, and
resolve the contradictory results obtained using hairpins and tiny-LNAs, we ob-
tained mice with the miR-181ab-1 locus deleted, and observed the level of CD69
in activated thymocytes and peripheral T-cells compared to wild-type controls.
This confirmed the results obtained using the reporter constructs and the hair-
pin inhibitors, showing that the miR-181 family targets CD69. Interestingly, in
the miR-181ab-1-deleted mice, an increase in CD69 expression was also seen in
peripheral T-cells, despite no change in expression of our Cd69 3’ UTR reporters
being seen in peripheral T-cells when the predicted miR-181 binding site was mu-
tated. This suggests that constitutive knockout of miR-181ab-1 may lead to devel-
opmental changes in the mechanisms of CD69 expression that result in increased
expression of CD69 on activation even after miR-181 expression has been down-
regulated. As with inhibition of miR-181 in thymocytes, no increase in CD69 CV
was observed in miR-181ab-1-deleted cells. This suggests that miR-181 regula-
tion of CD69 is not the primary mechanism responsible for the increase in CD69
CV seen in activated thymocytes.
Although our experiments confirm that CD69 is a direct miRNA target, the
question of how miRNAs may regulate noise needs further investigation: al-
though depletion of the miR-181 and miR-20 families, by deletion or LNA in-
hibition, showed increases in gene expression in activated thymocytes, unlike in
Dicer-deleted thymocytes, no increase in noise was seen. Noise remains an ex-
perimentally complex area to study, due to the requirement that experiments that
investigate mechanisms of noise must not introduce additional noise into the sys-
tem. This is particularly problematic in transcriptional circuits, as the response of
the circuit to a given perturbation cannot be intuitively predicted in the same way
as, for example, the response in mean levels of a particular mRNA to increasing
levels of a transcriptional activator can be. Our results show that CD69 shows in-
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creased noise in Dicer-depleted thymocytes, and that this Dicer-dependent noise
regulation is developmentally regulated, as it is not seen in mature T-cells. Ex-
periments using fluorescent reporter constructs, miRNA inhibitors and miRNA-
knockout mice have shown that Cd69 is a direct miRNA target. However, it is not
clear how exactly the depletion of small RNAs caused by Dicer-depletion results
in the increases in cell-cell variation we have seen.
Finally, we used computational simulations to investigate potential theoreti-
cal mechanisms by which miRNAs might regulate cell-cell variation. Although
we could not determine exact estimates for all the rate constants required to accu-
rately specify a model, simulating simple miRNA-containing FFLs with biolog-
ically plausible rate constants shows that such circuits can produce comparable
changes in mean protein expression and protein CV to our observations in exper-
imental systems. Interestingly, the regulation of variation appeared in both our
models of miRNA action, despite considerable differences in the two systems. We
also noted that in our miRNA-mRNA binding model, the relative levels of mean
expression and cell-cell variation could be independently altered by varying dif-
ferent parameters of miRNA action. In both systems, moderate regulation of bi-
ological noise occurred under a wide range of parameters, suggesting that noise
regulation is a robust property of the miRNA-containing FFL. While this model
shows that miRNA regulation might be capable of regulating cell-cell variation,
it is important to remember that the modelled system is a steady-state system,
where the various components have reached an equilibrium. In reality, particu-
larly in the case of the rapid induction of CD69 expression, this is unlikely to be
the case.
These results suggest two possible scenarios for the Dicer-dependent regula-
tion of CD69 noise. Firstly, CD69 could be regulated directly by a miRNA such
as miR-17 or miR-20a, which is upregulated on T-cell activation at the same time
as CD69 and could act in an incoherent FFL to reduce cell-cell variation (Figure
5.1a). In the case of the miR-20 family, this circuit must principally act to reduce
noise from a source specific to thymocytes, but which is not present in mature
T-cells. Secondly, some other upstream, Dicer-dependent mechanism such as the
miRNA regulation of components of the T-cell activation pathway, or other fac-
tors involved in T-cell maturation, could regulate CD69 cell-cell variation, which
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T-cell 
Activation 
miR-20 miRNA 
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CD69
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direct miRNA 
regulation
CD69
Dicer-dependent regulation of 
variation in  upstream 
regulators of CD69
Figure 5.1: Potential mechanisms for noise regulation of Cd69 - (a) CD69 expression
is regulated as part of an incoherent feed-forward loop in which T-cell activation
upregulates both the miR-20 family and CD69. (b) CD69 expression is regulated
by some other, upstream Dicer-dependent mechanism which is independent of the
direct miRNA regulation we have identified
results in an increase in CD69 variation in Dicer-deleted cells independent of the
direct regulation of CD69 by miRNAs (Figure 5.1b).
5.5 Future directions
These results suggest a number of future experiments. To continue to investi-
gate the regulation of Cd69 expression by miRNAs, further work on the effect of
deleting other Cd69-targeting miRNAs would allow better understanding of the
mechanisms by which Dicer-deletion results in an increase in noise. For exam-
ple, mice containing deletions of the miR-17-92 cluster have been generated, and
it would be interesting to investigate how deletion of the complete 17-92 cluster
compares with deletion of the miR-181ab cluster.
While my experiments show that specific genes show increased variation in
Dicer-deleted cells, the phenotypic effect of this regulation remains to be seen.
The functions of CD69, Sca-1 and CD44 are all still poorly understood, but a num-
ber of ligands and binding partners have been identified. For example, future
experiments could look at the effect of the increase in CD44 noise observed in
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Dicer-deleted cells on the response of cells to hyaluronic acid or other ligands of
CD44. Variation in levels of Sca-1 has already been shown to affect lineage choice
in haematopoietic progenitor cells, and to be associated with different levels of
transcription factors such as GATA1 or PU22. It would be interesting to investi-
gate whether similar effects can be observed in thymocytes. While no ligand has
yet been identified for CD69, future experiments could investigate the effect of
increased variation on the expression of S1P1, a binding partner of CD69, or on
thymic migration, which CD69 has been shown to influence176.
The control of CD69 noise during activation only in immature thymocytes is
particularly interesting, as it may reflect a broader mechanism of control that may
extend to other miRNA-regulated genes during selection: it would also be inter-
esting to investigate whether the increase in CD69 noise in activated thymocytes
is due in part to thymic selection. T-cell selection and activation is already un-
der precise control from a number of pathways: for example, the CD8 coreceptor
has been found to tune T-cell responsiveness216. As CD69 expression is upreg-
ulated by TCR-mediated activation, it would be interesting to see how much of
the noise seen in the thymus is due to varying TCR sensitivities, and whether this
noise regulation occurs in other genes induced by T-cell activation. This could be
investigated through the use of TCR-restricted mice such as OT1 or AND TCR
transgenic mice in Rag knockouts.
Further work on modelling the action of miRNAs would be useful: in partic-
ular, while a number of theoretical studies have simulated particular transcrip-
tion motifs or networks, relatively little work has been done to directly quan-
tify important constants which determine miRNA dynamics, such as the rates
of miRNA production and decay. With accurate measurements of these various
constants, different models of miRNA action can be simulated and tested against
experimental data more accurately, allowing the construction of better models
and the identification from these models of areas of miRNA action in need of
further investigation.
Future experiments may also expand into different experimental systems:
while T-cell development is a well-characterised system, the dynamics of T-cell
development make experiments such as efficient miRNA knockdowns experi-
mentally complicated, and may introduce additional variability into experiments.
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Future experiments could investigate the role of miRNAs in regulating variation
in other systems. For example, several miRNAs are known to be involved in em-
bryonic stem cell development, and there are a number of documented ES cell
miRNAs involved in regulation of the ES cell state.
Our results have shown that deletion of Dicer, an essential component of the
miRNA biogenesis pathway, results in an increase in both the mean level of ex-
pression and also the cell-cell variation in expression of particular proteins, in-
cluding highly expressed proteins such as CD69 in activated T-cells. Reporter
construct studies have identified CD69 as the target of a number of miRNAs in-
cluding the miR-181, miR-130 and miR-20 families. Regulation of CD69 by miR-
181 and miR-20 family members was confirmed by miRNA inhibition and dele-
tion experiments. Further work is needed to characterise the regulation of CD69
by miRNAs, and the mechanisms by which deletion of Dicer results in increases
in the cell-cell variation of specific genes.
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6Appendix 1
6.1 Basic Gillespie simulation function
Electronic copies of simulation code can be found at: https://github.com/RoryBlevins/PhD-
Thesis
# Gillespie simulation function
gillespied=function (N, T=100, dt=1, ...)
{
tt=0
n=T%/%dt
x=N$M
S=t(N$Post-N$Pre)
u=nrow(S)
v=ncol(S)
xmat=matrix(0,ncol=u,nrow=n)
i=1
target=0
repeat {
h=N$h(x, th, ...)
h0=sum(h)
if (h0<1e-10)
tt=1e99
else
tt=tt+rexp(1,h0)
while (tt>=target) {
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xmat[i,]=x
i=i+1
target=target+dt
if (i>n)
return(ts(xmat,start=0,deltat=dt))
}
j=sample(v,1,prob=h)
x=x+S[,j]
}
}
6.2 Simulation of miRNA FFL with translational in-
hibition
# test of miRNA-containing FFL
FFL=list()
#starting values
FFL$M=c(
100,100,100,100,100
)
#Reaction matrices
FFL$Pre=matrix(c(
0,0,0,0,0,
1,0,0,0,0,
1,0,0,0,0,
0,1,0,0,0,
0,0,0,0,0,
0,0,1,0,0,
0,0,0,0,0,
0,0,0,1,0,
0,0,0,1,0,
0,0,0,0,1
),ncol=5,byrow=TRUE)
FFL$Post=matrix(c(
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1,0,0,0,0,
0,0,0,0,0,
1,1,0,0,0,
0,0,0,0,0,
0,0,1,0,0,
0,0,0,0,0,
0,0,0,1,0,
0,0,0,0,0,
0,0,0,1,1,
0,0,0,0,0
),ncol=5,byrow=TRUE)
#rate constant calculation
FFL$h=function(x,th)
{
return(c(
th[1], #TF transcription
th[2]*x[1],#TF mRNA degradation
th[3]*x[1],#TF translation
th[4]*x[2],#TF protein degradation
(th[5]*x[2]^th[7])/(th[6]^th[7]+x[2]^th[7]),#miRNA transcription
th[8]*x[3],#miRNA degradation
(th[9]*x[2]^th[7])/(th[6]^th[7]+x[2]^th[7]),#output transcription
th[2]*x[4] ,#output mRNA degradation
(th[10]*x[4])/(1+(x[3]/th[11])^th[7]),#output translation
th[4]*x[5] #ouput degradation
))}
# test of miRNA-independent circuit
TF=list()
#starting values
TF$M=c(
100,100,100,100,100
)
#Reaction matrices
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TF$Pre=matrix(c(
0,0,0,0,0,
1,0,0,0,0,
1,0,0,0,0,
0,1,0,0,0,
0,0,0,0,0,
0,0,0,1,0,
0,0,0,1,0,
0,0,0,0,1
),ncol=5,byrow=TRUE)
TF$Post=matrix(c(
1,0,0,0,0,
0,0,0,0,0,
1,1,0,0,0,
0,0,0,0,0,
0,0,0,1,0,
0,0,0,0,0,
0,0,0,1,1,
0,0,0,0,0
),ncol=5,byrow=TRUE)
#rate constant calculation
TF$h=function(x,th)
{
return(c(
th[1], #TF transcription
th[2]*x[1],#TF mRNA degradation
th[3]*x[1],#TF translation
th[4]*x[2],#TF protein degradation
(th[9]*x[2]^th[7])/(th[6]^th[7]+x[2]^th[7]),#output transcription
th[2]*x[4] ,#output mRNA degradation
(th[10]*x[4]),#output translation
th[4]*x[5] #ouput degradation
))}
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#Timecourse data
T<- 5000
dt<- 10
measuretime <- 4000/dt
#number of simulations
n <- 200
#rate constants
th=c(
0.06, # transcription rate
0.006, # TF mRNA degradation rate
0.04, # TF translation rate
0.002,# TF protein degradation rate
0.5, # base miRNA transcription rate
200, # miRNA dissociation coefficient
2,# hill coefficient for miRNA
0.006,# miRNA degradation rate
0.8,# base output transcription rate
#200, # miRNA dissociation coefficient
#2,# hill coefficient for miRNA
#0.006, # output mRNA degradation rate
0.04, # base translation rate
60, # output translation repression
#2,# hill coefficient for translation
#0.002 # output protein degradation
)
#number of simulations
n <- 10000
FFLresults <- 0
TFresults <- 0
for (ii in (1:n)){
141
6. APPENDIX 1
FFLOutput <-gillespied(FFL,T,dt)
TFOutput <-gillespied(TF,T,dt)
if (ii%%10==0){
print(ii)
}
FFLresults <- rbind(FFLresults,FFLOutput[measuretime,])
TFresults <- rbind(TFresults, TFOutput[measuretime,])
}
TFresults <- TFresults[-1,]
FFLresults <- FFLresults[-1,]
TFMean <- mean(TFresults[,5])
FFLMean <- mean(FFLresults[,5])
TFSD <- sd(TFresults[,5])
FFLSD <- sd(FFLresults[,5])
RelativeMean <- TFMean/FFLMean
FFLCV <- FFLSD/FFLMean
TFCV <- TFSD/TFMean
RelativeCV <- TFCV/FFLCV
RelativeMean
RelativeCV
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6.3 Simulation of miRNA FFL with miRNA-mRNA
binding
# test of miRNA-containing FFL
FFL=list()
#starting values
FFL$M=c(
100, # TF mRNA
100, # TF protein
100,# miRNA
100,# Output mRNA
100,# Output protein
0 # miRNA-protein complex
)
#Reaction matrices
FFL$Pre=matrix(c(
0,0,0,0,0,0,# TF transcription
1,0,0,0,0,0,# TF mRNA degradation
1,0,0,0,0,0,# TF translation
0,1,0,0,0,0,# TF protein degradation
0,0,0,0,0,0,# miRNA transcription
0,0,1,0,0,0,# miRNA degradation
0,0,1,1,0,0,# miRNA-output mRNA binding
0,0,0,0,0,1,# miRNA-output mRNA dissociation
0,0,0,0,0,1,# miRNA-output mRNA degradation of mRNA
0,0,0,0,0,0,# Output transcription
0,0,0,1,0,0,# Output mRNA degradation
0,0,0,1,0,0,# Output translation
0,0,0,0,1,0 # Output protein degradation
),ncol=6,byrow=TRUE)
FFL$Post=matrix(c(
1,0,0,0,0,0,# TF transcription
0,0,0,0,0,0,# TF mRNA degradation
1,1,0,0,0,0,# TF translation
0,0,0,0,0,0,# TF protein degradation
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0,0,1,0,0,0,# miRNA transcription
0,0,0,0,0,0,# miRNA degradation
0,0,0,0,0,1,# miRNA-output mRNA binding
0,0,1,1,0,0,# miRNA-output mRNA dissociation
0,0,1,0,0,0,# miRNA-output mRNA degradation of mRNA
0,0,0,1,0,0,# Output transcription
0,0,0,0,0,0,# Output mRNA degradation
0,0,0,1,1,0,# Output translation
0,0,0,0,0,0 # Output protein degradation
),ncol=6,byrow=TRUE)
)
#rate constant calculation
FFL$h=function(x,th)
{
return(c(
th[1], #TF transcription
th[2]*x[1],#TF mRNA degradation
th[3]*x[1],#TF translation
th[4]*x[2],#TF protein degradation
(th[5]*x[2]^th[7])/(th[6]^th[7]+x[2]^th[7]),#miRNA transcription
th[8]*x[3],#miRNA degradation
th[9]*x[3]*x[4],# miRNA-output mRNA binding
th[10]*x[6] ,# miRNA-output mRNA dissociation
th[11]*x[6] ,# miRNA-output mRNA degradation of mRNA
(th[12]*x[2]^th[14])/(th[13]^th[14]+x[2]^th[14]),#output transcription
th[15]*x[4],#output mRNA degradation
th[16]*x[4],#output translation
th[17]*x[5] #ouput degradation
))}
# test of miRNA-independent circuit
TF=list()
#starting values
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TF$M=c(
100, # TF mRNA
100, # TF protein
100,# miRNA
100,# Output mRNA
100,# Output protein
0 # miRNA-protein complex
)
#Reaction matrices
TF$Pre=matrix(c(
0,0,0,0,0,0,# TF transcription
1,0,0,0,0,0,# TF mRNA degradation
1,0,0,0,0,0,# TF translation
0,1,0,0,0,0,# TF protein degradation
0,0,0,0,0,0,# Output transcription
0,0,0,1,0,0,# Output mRNA degradation
0,0,0,1,0,0,# Output translation
0,0,0,0,1,0 # Output protein degradation
),ncol=6,byrow=TRUE)
TF$Post=matrix(c(
1,0,0,0,0,0,# TF transcription
0,0,0,0,0,0,# TF mRNA degradation
1,1,0,0,0,0,# TF translation
0,0,0,0,0,0,# TF protein degradation
0,0,0,1,0,0,# Output transcription
0,0,0,0,0,0,# Output mRNA degradation
0,0,0,1,1,0,# Output translation
0,0,0,0,0,0 # Output protein degradation
),ncol=6,byrow=TRUE)
#rate constant calculation
TF$h=function(x,th)
{
return(c(
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th[1], #TF transcription
th[2]*x[1],#TF mRNA degradation
th[3]*x[1],#TF translation
th[4]*x[2],#TF protein degradation
(th[12]*x[2]^th[14])/(th[13]^th[14]+x[2]^th[14]),#output transcription
th[15]*x[4],#output mRNA degradation
th[16]*x[4],#output translation
th[17]*x[5] #ouput degradation
))}
#Timecourse data
T<- 5000
dt<- 10
measuretime <- 4000/dt
#rate constants
th=c(
0.06, # transcription rate
0.006, # TF mRNA degradation rate
0.04, # TF translation rate
0.002,# TF protein degradation rate
0.5, # base miRNA transcription rate
200, # miRNA dissociation coefficient
2,# hill coefficient for miRNA
0.006,# miRNA degradation rate
0.0001,# miRNA complex formation rate
0.0001,# miRNA-mRNA dissociation rate
0.02, # miRNA-mRNA degradation rate
0.8,# base output transcription rate
200, # mRNA dissociation coefficient
2,# hill coefficient for transcription
0.006, # output mRNA degradation rate
0.04, # base translation rate
0.002 # output protein degradation
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#number of simulations
n <- 10000
FFLresults <- 0
TFresults <- 0
for (ii in (1:n)){
FFLOutput <-gillespied(FFL,T,dt)
TFOutput <-gillespied(TF,T,dt)
if (ii%%10==0){
print(ii)
}
FFLresults <- rbind(FFLresults,FFLOutput[measuretime,])
TFresults <- rbind(TFresults, TFOutput[measuretime,])
}
TFresults <- TFresults[-1,]
FFLresults <- FFLresults[-1,]
TFMean <- mean(TFresults[,5])
FFLMean <- mean(FFLresults[,5])
TFSD <- sd(TFresults[,5])
FFLSD <- sd(FFLresults[,5])
RelativeMean <- TFMean/FFLMean
FFLCV <- FFLSD/FFLMean
TFCV <- TFSD/TFMean
RelativeCV <- TFCV/FFLCV
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RelativeMean
RelativeCV
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